Cardiology Today

Welcome to Cardiology Today – Recorded April 07, 2026. This episode summarizes 5 key cardiology studies on topics like guideline-directed medical therapy and congenital heart disease. Key takeaway: Telomere Recapping Blocks Heart Failure Mechanism. Article Links: Article 1: Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood-Brain Barrier Integrity. (Circulation) Article 2: A Randomized Controlled Trial Comparing Different Programming Strategies of Left Bundle Branch Area Pacing on Left Atrial Volume and Atrial High-Rate Episodes in Patients With Sinus Node Dysfunction. (The American journal of cardiology) Article 3: Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failure. (Cardiovascular research) Article 4: Longitudinal trajectories of secondary mitral regurgitation in non-ischemic dilated cardiomyopathy. (Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography) Article 5: Stress, coping, protective factors, and quality of life in parents of infants with CHD: associations with state anxiety. (Cardiology in the young) Full episode page: https://podcast.explainheart.com/podcast/telomere-recapping-blocks-heart-failure-mechanism-04-07-26/ Featured Articles Article 1: Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood-Brain Barrier Integrity. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41645912 Summary: D. 36, Is Essential for Blood-Brain Barrier Integrity. This study found that Apolipoprotein D is a novel ligand for C. D. 36 and is essential for maintaining blood-brain barrier integrity. This mechanism is critical because disruption of the blood-brain barrier is a central pathogenic event in many central nervous system disorders. The research identifies a specific molecular pathway governing blood-brain barrier function. This fundamental understanding of blood-brain barrier regulation provides a basis for future therapeutic strategies. Article 2: A Randomized Controlled Trial Comparing Different Programming Strategies of Left Bundle Branch Area Pacing on Left Atrial Volume and Atrial High-Rate Episodes in Patients With Sinus Node Dysfunction. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41942043 Summary: Left bundle branch area pacing is a physiological pacing modality preserving ventricular synchrony. Optimal programming strategies for patients with sinus node dysfunction, particularly those with delayed intrinsic atrioventricular conduction, have remained clinically uncertain. It is understood that minimal ventricular pacing algorithms can permit non-physiological atrioventricular prolongation, which contributes to left atrial remodeling and atrial high-rate episodes. This randomized controlled trial directly compared maximal atrioventricular sequential pacing with minimal ventricular pacing strategies to address these critical clinical outcomes. Article 3: Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failure. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41942104 Summary: N. A. communication in heart failure. This study found that telomere recapping prevents pathogenic communication between telomeres and mitochondrial deoxyribonucleic acid in heart failure. Diseased cardiomyocytes exhibit telomeric shortening, which triggers deoxyribonucleic acid damage responses and leads to mitochondrial dysfunction. This finding demonstrates a novel mechanism to restore myocardial function, addressing the high prevalence and significant mortality of heart failure, where five-year survival remains at fifty percent. Telomere recapping thus represents a promising therapeutic target for improving heart failure outcomes. Article 4: Longitudinal trajectories of secondary mitral regurgitation in non-ischemic dilated cardiomyopathy. Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41941940 Summary: This study defined the longitudinal trajectories of secondary mitral regurgitation in 764 patients with non-ischemic dilated cardiomyopathy. The findings revealed the dynamic nature of secondary mitral regurgitation severity, demonstrating its dependence on loading conditions and guideline-directed medical therapy. Understanding these long-term trajectories provides crucial prognostic insights for patients with non-ischemic dilated cardiomyopathy. This research provides a framework for evaluating secondary mitral regurgitation evolution and guiding patient management. Article 5: Stress, coping, protective factors, and quality of life in parents of infants with CHD: associations with state anxiety. Journal: Cardiology in the young PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41940517 Summary: H. D.: associations with state anxiety. The Family Adaptation study identified associations between stress, coping mechanisms, protective factors, quality of life, and state anxiety in parents of infants with congenital heart disease. The study included 215 parents, comprising 143 mothers and 72 fathers, of 146 infants who underwent the Norwood procedure, with measurements taken post-Norwood and post-Stage two. Results showed specific relationships among these psychosocial factors across the parental cohort. These findings delineate the complex psychosocial landscape and provide crucial insights for supporting parental well-being during their infant’s critical cardiac care. Transcript Today’s date is April 07, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Apolipoprotein D, a Novel Ligand for C. D. 36, Is Essential for Blood-Brain Barrier Integrity. This study found that Apolipoprotein D is a novel ligand for C. D. 36 and is essential for maintaining blood-brain barrier integrity. This mechanism is critical because disruption of the blood-brain barrier is a central pathogenic event in many central nervous system disorders. The research identifies a specific molecular pathway governing blood-brain barrier function. This fundamental understanding of blood-brain barrier regulation provides a basis for future therapeutic strategies. Article number two. A Randomized Controlled Trial Comparing Different Programming Strategies of Left Bundle Branch Area Pacing on Left Atrial Volume and Atrial High-Rate Episodes in Patients With Sinus Node Dysfunction. Left bundle branch area pacing is a physiological pacing modality preserving ventricular synchrony. Optimal programming strategies for patients with sinus node dysfunction, particularly those with delayed intrinsic atrioventricular conduction, have remained clinically uncertain. It is understood that minimal ventricular pacing algorithms can permit non-physiological atrioventricular prolongation, which contributes to left atrial remodeling and atrial high-rate episodes. This randomized controlled trial directly compared maximal atrioventricular sequential pacing with minimal ventricular pacing strategies to address these critical clinical outcomes. Article number three. Telomere recapping prevents pathogenic telomere-to-mitochondrial D. N. A. communication in heart failure. This study found that telomere recapping prevents pathogenic communication between telomeres and mitochondrial deoxyribonucleic acid in heart failure. Diseased cardiomyocytes exhibit telomeric shortening, which triggers deoxyribonucleic acid damage responses and leads to mitochondrial dysfunction. This finding demonstrates a novel mechanism to restore myocardial function, addressing the high prevalence and significant mortality of heart failure, where five-year survival remains at fifty percent. Telomere recapping thus represents a promising therapeutic target for improving heart failure outcomes. Article number four. Longitudinal trajectories of secondary mitral regurgitation in non-ischemic dilated cardiomyopathy. This study defined the longitudinal trajectories of secondary mitral regurgitation in 764 patients with non-ischemic dilated cardiomyopathy. The findings revealed the dynamic nature of secondary mitral regurgitation severity, demonstrating its dependence on loading conditions and guideline-directed medical therapy. Understanding these long-term trajectories provides crucial prognostic insights for patients with non-ischemic dilated cardiomyopathy. This research provides a framework for evaluating secondary mitral regurgitation evolution and guiding patient management. Article number five. Stress, coping, protective factors, and quality of life in parents of infants with C. H. D.: associations with state anxiety. The Family Adaptation study identified associations between stress, coping mechanisms, protective factors, quality of life, and state anxiety in parents of infants with congenital heart disease. The study included 215 parents, comprising 143 mothers and 72 fathers, of 146 infants who underwent the Norwood procedure, with measurements taken post-Norwood and post-Stage two. Results showed specific relationships among these psychosocial factors across the parental cohort. These findings delineate the complex psychosocial landscape and provide crucial insights for supporting parental well-being during their infant’s critical cardiac care. Thank you for listening. Don’t forget to subscribe. Keywords guideline-directed medical therapy, congenital heart disease, parental anxiety, heart failure, apolipoprotein D, mitochondrial D. N. A., telomere recapping, atrial high-rate episodes, ligand, quality of life, blood-brain barrier, atrioventricular conduction, secondary mitral regurgitation, left bundle branch area pacing, Norwood procedure, echocardiography, sinus node dysfunction, prognosis, C. D. 36, left atrial volume, non-ischemic dilated cardiomyopathy, central nervous syst

Welcome to Cardiology Today – Recorded April 06, 2026. This episode summarizes 5 key cardiology studies on topics like rehabilitation needs and coronary computed tomography angiography. Key takeaway: AI C. C. T. A. Guides Optimal L. L. M. Benefit. Article Links: Article 1: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. (ESC heart failure) Article 2: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. (ESC heart failure) Article 3: Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. (Circulation. Cardiovascular imaging) Article 4: The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. (Cardiology in the young) Article 5: Physical therapy enhances patient care in post-congenital heart surgery clinic. (Cardiology in the young) Full episode page: https://podcast.explainheart.com/podcast/ai-c-c-t-a-guides-optimal-l-l-m-benefit-04-06-26/ Featured Articles Article 1: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41941602 Summary: This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article 2: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41941602 Summary: This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article 3: Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. Journal: Circulation. Cardiovascular imaging PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41937634 Summary: This observational cohort study found that artificial intelligence-guided quantitative coronary computed tomography angiography identified patients who derive outcome benefit from lipid-lowering medication. The study showed that quantification of coronary atherosclerotic plaque burden, specifically percent atheroma volume, serves as a marker for guiding therapy. This demonstrates that advanced imaging can personalize lipid-lowering medication strategies for symptomatic patients with suspected coronary artery disease. Article 4: The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. Journal: Cardiology in the young PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41940521 Summary: This retrospective study found that the inferior vena cava collapsibility index serves as a non-invasive marker for early hemodynamic changes following transcatheter closure of an atrial septal defect. The study assessed changes in pulmonary artery, pulmonary vein, and inferior vena cava flow parameters in 31 pediatric patients. This demonstrates a valuable tool for monitoring immediate post-procedural cardiovascular adjustments in young patients with hemodynamically significant atrial septal defects, defined as Qp over Qs greater than or equal to 1.5. Article 5: Physical therapy enhances patient care in post-congenital heart surgery clinic. Journal: Cardiology in the young PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41940519 Summary: This retrospective review found that routine physical therapy evaluation significantly enhances patient care in post-congenital heart surgery clinics. The study assessed posture, mobility, and pain in patients following congenital heart surgery requiring sternotomy. This demonstrated that physical therapy effectively identifies rehabilitation needs and addresses gaps in care, improving post-operative management for these patients. Transcript Today’s date is April 06, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article number two. Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article number three. Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. This observational cohort study found that artificial intelligence-guided quantitative coronary computed tomography angiography identified patients who derive outcome benefit from lipid-lowering medication. The study showed that quantification of coronary atherosclerotic plaque burden, specifically percent atheroma volume, serves as a marker for guiding therapy. This demonstrates that advanced imaging can personalize lipid-lowering medication strategies for symptomatic patients with suspected coronary artery disease. Article number four. The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. This retrospective study found that the inferior vena cava collapsibility index serves as a non-invasive marker for early hemodynamic changes following transcatheter closure of an atrial septal defect. The study assessed changes in pulmonary artery, pulmonary vein, and inferior vena cava flow parameters in 31 pediatric patients. This demonstrates a valuable tool for monitoring immediate post-procedural cardiovascular adjustments in young patients with hemodynamically significant atrial septal defects, defined as Qp over Qs greater than or equal to 1.5. Article number five. Physical therapy enhances patient care in post-congenital heart surgery clinic. This retrospective review found that routine physical therapy evaluation significantly enhances patient care in post-congenital heart surgery clinics. The study assessed posture, mobility, and pain in patients following congenital heart surgery requiring sternotomy. This demonstrated that physical therapy effectively identifies rehabilitation needs and addresses gaps in care, improving post-operative management for these patients. Thank you for listening. Don’t forget to subscribe. Keywords rehabilitation needs, coronary computed tomography angiography, functional capacity, post-operative care, Heart Failure, patient-reported health status, atherosclerotic plaque burden, ejection fraction, artificial intelligence, physical therapy, inferior vena cava collapsibility index, lipid-lowering medication, congenital heart surgery, pediatric cardiology, hemodynamic changes, percent atheroma volume, atrial septal defect, transcatheter closure, cardiac microcurrent therapy. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post AI C. C. T. A. Guides Optimal L. L. M. Benefit 04/06/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded April 06, 2026. This episode summarizes 5 key cardiology studies on topics like heart failure with preserved ejection fraction and coronary artery bypass grafting. Key takeaway: NOBLE Trial’s 10-Year Left Main Data. Article Links: Article 1: Beyond ion channel dysfunction: Integration of the transcriptome and proteome from patient-specific re-engineered cardiac cells, and population-level QT genome-wide association study reveals broad cellular dysfunction. (Heart rhythm) Article 2: Utilization and Outcomes of Dual Antiplatelet Therapy in Patients with Active Cancer Presenting with Acute Myocardial Infarction: A Global Registry Study. (The American journal of cardiology) Article 3: Cardiovascular pharmacotherapy in year in 2025. (European heart journal. Cardiovascular pharmacotherapy) Article 4: Economic Burden Associated with Systemic Inflammation in Patients with HFmrEF/HFpEF. (American heart journal) Article 5: Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial. (Lancet (London, England)) Full episode page: https://podcast.explainheart.com/podcast/noble-trials-10-year-left-main-data-04-06-26/ Featured Articles Article 1: Beyond ion channel dysfunction: Integration of the transcriptome and proteome from patient-specific re-engineered cardiac cells, and population-level QT genome-wide association study reveals broad cellular dysfunction. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41936938 Summary: The study demonstrated broad cellular dysfunction in congenital Long Q. T. syndrome. This finding emerged from integrating transcriptomic and proteomic profiles of patient-derived inducible pluripotent stem cell-derived cardiomyocyte models representing L. Q. T. type one, L. Q. T. type two, and L. Q. T. type three genotypes. The investigation also incorporated population-level Q. T. genome-wide association study data, revealing cellular impairments beyond mere ion channel dysfunction and providing a deeper understanding of the disease’s mechanisms. Article 2: Utilization and Outcomes of Dual Antiplatelet Therapy in Patients with Active Cancer Presenting with Acute Myocardial Infarction: A Global Registry Study. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41936851 Summary: The global registry study characterized the utilization patterns and associated outcomes of dual antiplatelet therapy in patients with active cancer experiencing acute myocardial infarction. The investigation addressed the critical clinical challenge of balancing competing risks of thrombosis and bleeding when selecting optimal therapy in this high-mortality population. It comprehensively analyzed therapy use and outcomes, with all-cause mortality serving as the primary endpoint in these complex patients. Article 3: Cardiovascular pharmacotherapy in year in 2025. Journal: European heart journal. Cardiovascular pharmacotherapy PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41935384 Summary: Significant advances in cardiovascular pharmacotherapy were identified, including the approval of four new drugs: aficamten, etripamil, lerodalcibep, and plozasiran. Additionally, five already approved drugs received label expansions, broadening their therapeutic applications. The review also summarized key findings from major randomized clinical trials that further advanced treatment strategies, collectively addressing the ongoing need for more effective and safer pharmacological interventions across various cardiovascular diseases. Article 4: Economic Burden Associated with Systemic Inflammation in Patients with HFmrEF/HFpEF. Journal: American heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41936927 Summary: This retrospective cohort study characterized the economic burden associated with systemic inflammation in patients with heart failure with mildly reduced ejection fraction or heart failure with preserved ejection fraction. The investigation demonstrated the impact of systemic inflammation on real-world healthcare resource utilization and costs within this specific patient population. The findings highlight the critical role of systemic inflammation, detected via high sensitivity C. R. P. testing, in both the pathogenesis and economic implications for these heart failure subtypes. Article 5: Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial. Journal: Lancet (London, England) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41936368 Summary: The N. O. B. L. E. trial delivered its 10-year final results, directly comparing percutaneous coronary intervention with newer generation drug-eluting stents against coronary artery bypass grafting for unprotected left main coronary artery stenosis. This randomized, open-label, non-inferiority investigation provided crucial long-term outcome data in a patient population where coronary artery bypass grafting has traditionally been the recommended treatment. The study offered definitive long-term insights to guide treatment decisions for this significant cardiovascular condition. Transcript Today’s date is April 06, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Beyond ion channel dysfunction: Integration of the transcriptome and proteome from patient-specific re-engineered cardiac cells, and population-level QT genome-wide association study reveals broad cellular dysfunction. The study demonstrated broad cellular dysfunction in congenital Long Q. T. syndrome. This finding emerged from integrating transcriptomic and proteomic profiles of patient-derived inducible pluripotent stem cell-derived cardiomyocyte models representing L. Q. T. type one, L. Q. T. type two, and L. Q. T. type three genotypes. The investigation also incorporated population-level Q. T. genome-wide association study data, revealing cellular impairments beyond mere ion channel dysfunction and providing a deeper understanding of the disease’s mechanisms. Article number two. Utilization and Outcomes of Dual Antiplatelet Therapy in Patients with Active Cancer Presenting with Acute Myocardial Infarction: A Global Registry Study. The global registry study characterized the utilization patterns and associated outcomes of dual antiplatelet therapy in patients with active cancer experiencing acute myocardial infarction. The investigation addressed the critical clinical challenge of balancing competing risks of thrombosis and bleeding when selecting optimal therapy in this high-mortality population. It comprehensively analyzed therapy use and outcomes, with all-cause mortality serving as the primary endpoint in these complex patients. Article number three. Cardiovascular pharmacotherapy in year in 2025. Significant advances in cardiovascular pharmacotherapy were identified, including the approval of four new drugs: aficamten, etripamil, lerodalcibep, and plozasiran. Additionally, five already approved drugs received label expansions, broadening their therapeutic applications. The review also summarized key findings from major randomized clinical trials that further advanced treatment strategies, collectively addressing the ongoing need for more effective and safer pharmacological interventions across various cardiovascular diseases. Article number four. Economic Burden Associated with Systemic Inflammation in Patients with HFmrEF/HFpEF. This retrospective cohort study characterized the economic burden associated with systemic inflammation in patients with heart failure with mildly reduced ejection fraction or heart failure with preserved ejection fraction. The investigation demonstrated the impact of systemic inflammation on real-world healthcare resource utilization and costs within this specific patient population. The findings highlight the critical role of systemic inflammation, detected via high sensitivity C. R. P. testing, in both the pathogenesis and economic implications for these heart failure subtypes. Article number five. Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial. The N. O. B. L. E. trial delivered its 10-year final results, directly comparing percutaneous coronary intervention with newer generation drug-eluting stents against coronary artery bypass grafting for unprotected left main coronary artery stenosis. This randomized, open-label, non-inferiority investigation provided crucial long-term outcome data in a patient population where coronary artery bypass grafting has traditionally been the recommended treatment. The study offered definitive long-term insights to guide treatment decisions for this significant cardiovascular condition. Thank you for listening. Don’t forget to subscribe. Keywords heart failure with preserved ejection fraction, coronary artery bypass grafting, label expansions, proteome, high sensitivity C. R. P., cellular dysfunction, N. O. B. L. E. trial, heart failure with mildly reduced ejection fraction, aficamten, percutaneous coronary intervention, transcriptome, healthcare resource utilization, randomized clinical trials, thrombosis risk, new drug approvals, congenital Long Q. T. syndrome, cardiovascular pharmacotherapy, bleeding risk, active cancer, systemic inflammation, drug-eluting stents, unprotected left main coronary artery disease, inducible pluripotent stem cell-derived cardiomyocytes, acute myocardial infarction, dual antiplatelet therapy. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post NOBLE Trial’s 10-Year Left Main Data 04/06/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded April 05, 2026. This episode summarizes 2 key cardiology studies on topics like excitation-contraction coupling and right heart catheterization. Key takeaway: Stroke Volume Index for Pediatric P.A.H. Prognosis. Article Links: Article 1: Long-term genetic Orai1 inhibition modulates excitation-contraction coupling in female adult mouse ventricular cardiomyocytes. (American journal of physiology. Heart and circulatory physiology) Article 2: Clinical Utility of Stroke Volume Index in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension. (Pediatric cardiology) Full episode page: https://podcast.explainheart.com/podcast/stroke-volume-index-for-pediatric-p-a-h-prognosis-04-05-26/ Featured Articles Article 1: Long-term genetic Orai1 inhibition modulates excitation-contraction coupling in female adult mouse ventricular cardiomyocytes. Journal: American journal of physiology. Heart and circulatory physiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41926628 Summary: This study found that long-term genetic inhibition of Orai1, a store-operated calcium channel, modulates excitation-contraction coupling in adult mouse ventricular cardiomyocytes. Using a mouse model expressing a dominant-negative human Orai1R91W mutant, researchers observed elevated intracellular calcium transients and calcium spark amplitudes in female mice compared to wild-type controls. These specific findings demonstrate a sex-specific contribution of Orai1 to cardiac excitation-contraction coupling. This indicates a novel role for Orai1 in cardiac function that varies between sexes. Article 2: Clinical Utility of Stroke Volume Index in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension. Journal: Pediatric cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41925853 Summary: This retrospective study determined the clinical utility of stroke volume index in children with idiopathic and heritable pulmonary arterial hypertension. It assessed the prognostic value of stroke volume index, which was evaluated by right heart catheterization, in 103 pediatric patients. The study found a relationship between stroke volume index and adverse outcomes, specifically lung transplant and cardiac death. These findings establish stroke volume index as a valuable prognostic indicator in this pediatric patient population. Transcript Today’s date is April 05, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Long-term genetic Orai1 inhibition modulates excitation-contraction coupling in female adult mouse ventricular cardiomyocytes. This study found that long-term genetic inhibition of Orai1, a store-operated calcium channel, modulates excitation-contraction coupling in adult mouse ventricular cardiomyocytes. Using a mouse model expressing a dominant-negative human Orai1R91W mutant, researchers observed elevated intracellular calcium transients and calcium spark amplitudes in female mice compared to wild-type controls. These specific findings demonstrate a sex-specific contribution of Orai1 to cardiac excitation-contraction coupling. This indicates a novel role for Orai1 in cardiac function that varies between sexes. Article number two. Clinical Utility of Stroke Volume Index in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension. This retrospective study determined the clinical utility of stroke volume index in children with idiopathic and heritable pulmonary arterial hypertension. It assessed the prognostic value of stroke volume index, which was evaluated by right heart catheterization, in 103 pediatric patients. The study found a relationship between stroke volume index and adverse outcomes, specifically lung transplant and cardiac death. These findings establish stroke volume index as a valuable prognostic indicator in this pediatric patient population. Thank you for listening. Don’t forget to subscribe. Keywords excitation-contraction coupling, right heart catheterization, sex-specific differences, pediatric cardiology, pulmonary arterial hypertension, calcium transients, ventricular cardiomyocytes, Orai1 channel, Stroke volume index, prognostic value. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Stroke Volume Index for Pediatric P.A.H. Prognosis 04/05/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded April 05, 2026. This episode summarizes 5 key cardiology studies on topics like wall thickness heterogeneity and hypertrophic cardiomyopathy. Key takeaway: TCF21 Protects Heart Against Fibrosis. Article Links: Article 1: Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients. (Cardiovascular research) Article 2: Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. (Cardiovascular research) Article 3: How Accurate Is Inpatient Blood Pressure Measurement? (Hypertension (Dallas, Tex. : 1979)) Article 4: Epicardial-to-Endocardial Activation Gradients and Conduction Block During Atrial Fibrillation in the Human Left Atrial Posterior Wall. (Circulation. Arrhythmia and electrophysiology) Article 5: MRI-derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. (European heart journal. Cardiovascular Imaging) Full episode page: https://podcast.explainheart.com/podcast/tcf21-protects-heart-against-fibrosis-04-05-26/ Featured Articles Article 1: Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41928451 Summary: This study revealed a homogenization of the right and left atrial proteomes in patients with persistent atrial fibrillation. Researchers used a proteomic approach to investigate atrial fibrillation-associated remodeling in the right atrium relative to the left atrium. The data showed that protein profiles in both atria become similar during persistent atrial fibrillation. This finding indicates widespread atrial remodeling extending beyond the left atrium in this patient population. Article 2: Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41926244 Summary: Single nucleus R. N. A. sequencing and functional in vivo studies demonstrated that TCF21 acts as a protective regulator in cardiac fibrosis. This research specifically identified TCF21 as a novel cell-specific candidate gene involved in cardiac fibrosis. The study validated the functional impact of TCF21 using both in vitro and in vivo models. These findings offer a significant breakthrough for cardiac fibrosis, an untreatable contributor to mortality in chronic heart disease. Article 3: How Accurate Is Inpatient Blood Pressure Measurement? Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41930396 Summary: Observations were conducted across three noncritical care wards: aged care, acute surgical, and hematology, over a three-week period. The investigation revealed that no existing guidelines for accurate inpatient blood pressure measurement are currently in place. This highlights a critical need for standardized quality techniques in this clinical setting. Article 4: Epicardial-to-Endocardial Activation Gradients and Conduction Block During Atrial Fibrillation in the Human Left Atrial Posterior Wall. Journal: Circulation. Arrhythmia and electrophysiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41930410 Summary: This study characterized endocardial and epicardial left atrial posterior wall activation in humans during atrial fibrillation. Researchers identified epicardial-to-endocardial activation gradients and conduction blocks within the left atrial posterior wall. The findings demonstrated the prevalence of asynchronous endocardial-epicardial conduction in this region for patients with symptomatic nonparoxysmal atrial fibrillation. This research provides crucial insights into three-dimensional myocardial activation patterns during atrial fibrillation. Article 5: MRI-derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. Journal: European heart journal. Cardiovascular Imaging PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41923453 Summary: R. I. derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. This study demonstrated that wall thickness standard deviation, reflecting wall thickness heterogeneity, improves the identification of hypertrophic cardiomyopathy and sarcomere mutation carriers. Researchers utilized cardiac magnetic resonance imaging in 382 healthy controls, 297 patients with hypertrophic cardiomyopathy, and 82 sarcomere mutation carriers. The data showed that this measure helps identify early or subtle phenotypes missed by absolute wall thickness cut-offs. This method enhances diagnostic capabilities, particularly for mutation carriers. Transcript Today’s date is April 05, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients. This study revealed a homogenization of the right and left atrial proteomes in patients with persistent atrial fibrillation. Researchers used a proteomic approach to investigate atrial fibrillation-associated remodeling in the right atrium relative to the left atrium. The data showed that protein profiles in both atria become similar during persistent atrial fibrillation. This finding indicates widespread atrial remodeling extending beyond the left atrium in this patient population. Article number two. Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. Single nucleus R. N. A. sequencing and functional in vivo studies demonstrated that TCF21 acts as a protective regulator in cardiac fibrosis. This research specifically identified TCF21 as a novel cell-specific candidate gene involved in cardiac fibrosis. The study validated the functional impact of TCF21 using both in vitro and in vivo models. These findings offer a significant breakthrough for cardiac fibrosis, an untreatable contributor to mortality in chronic heart disease. Article number three. How Accurate Is Inpatient Blood Pressure Measurement? This study assessed the performance of routine blood pressure measurements in a major teaching hospital. Observations were conducted across three noncritical care wards: aged care, acute surgical, and hematology, over a three-week period. The investigation revealed that no existing guidelines for accurate inpatient blood pressure measurement are currently in place. This highlights a critical need for standardized quality techniques in this clinical setting. Article number four. Epicardial-to-Endocardial Activation Gradients and Conduction Block During Atrial Fibrillation in the Human Left Atrial Posterior Wall. This study characterized endocardial and epicardial left atrial posterior wall activation in humans during atrial fibrillation. Researchers identified epicardial-to-endocardial activation gradients and conduction blocks within the left atrial posterior wall. The findings demonstrated the prevalence of asynchronous endocardial-epicardial conduction in this region for patients with symptomatic nonparoxysmal atrial fibrillation. This research provides crucial insights into three-dimensional myocardial activation patterns during atrial fibrillation. Article number five. M. R. I. derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. This study demonstrated that wall thickness standard deviation, reflecting wall thickness heterogeneity, improves the identification of hypertrophic cardiomyopathy and sarcomere mutation carriers. Researchers utilized cardiac magnetic resonance imaging in 382 healthy controls, 297 patients with hypertrophic cardiomyopathy, and 82 sarcomere mutation carriers. The data showed that this measure helps identify early or subtle phenotypes missed by absolute wall thickness cut-offs. This method enhances diagnostic capabilities, particularly for mutation carriers. Thank you for listening. Don’t forget to subscribe. Keywords wall thickness heterogeneity, hypertrophic cardiomyopathy, single nucleus R. N. A. sequencing, atrial fibrillation, blood pressure measurement, epicardial, persistent atrial fibrillation, sarcomere gene mutations, proteome profiling, conduction block, diagnostic criteria, left atrial posterior wall, left atrium, TCF21, right atrium, measurement accuracy, protective regulator, endocardial, hospital practice, clinical guidelines, cardiac magnetic resonance, aortic stenosis, inpatient care, cardiac fibrosis. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post TCF21 Protects Heart Against Fibrosis 04/05/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded April 04, 2026. This episode summarizes 5 key cardiology studies on topics like arrhythmia vulnerability and catheter ablation. Key takeaway: Senolytics Prevent Atrial Arrhythmias in Elderly. Article Links: Article 1: Impact of left atrial posterior wall isolation using pulsed-field ablation in patients undergoing repeat catheter ablation for atrial fibrillation. (Heart rhythm) Article 2: Comparison of combined anatomic and functional modeling with purely anatomic assessment in scar-dependent ventricular tachycardia. (Heart rhythm) Article 3: Senolytic reduction of senescent cells mitigates atrial arrhythmia vulnerability in aging rabbits. (Heart rhythm) Article 4: Real-world performance of intrinsic antitachycardia pacing: Primary results from a global prospective postapproval registry study. (Heart rhythm) Article 5: Purkinje and septal substrate modification as a therapeutic option for patients with STEMI and refractory ventricular fibrillation. (Heart rhythm) Full episode page: https://podcast.explainheart.com/podcast/senolytics-prevent-atrial-arrhythmias-in-elderly-04-04-26/ Featured Articles Article 1: Impact of left atrial posterior wall isolation using pulsed-field ablation in patients undergoing repeat catheter ablation for atrial fibrillation. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41519351 Summary: For patients undergoing repeat catheter ablation for atrial fibrillation (AF), a therapeutic approach involves either redo pulmonary vein isolation (PVI) alone or combining redo PVI with adjunctive posterior wall isolation (PWI). The use of pulsed-field ablation (PFA) is a significant consideration for achieving durable isolation in these procedures. This strategy directly addresses the clinical challenge of recurrent atrial fibrillation by targeting both pulmonary veins and the posterior wall. The comparison of these two ablation strategies provides insights into optimizing outcomes in repeat atrial fibrillation interventions. Article 2: Comparison of combined anatomic and functional modeling with purely anatomic assessment in scar-dependent ventricular tachycardia. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41513062 Summary: Identifying the critical substrate in scar-dependent ventricular tachycardia (VT) relies on precise mapping for ablation targets. Cardiac magnetic resonance imaging (M. R. I.) provides anatomic assessment (A. A.) to detect channels sustaining ventricular tachycardia. A refined approach involves heart digital twins, which integrate anatomic data with functional assessment for identifying the ventricular tachycardia isthmus. This combined anatomic and functional modeling offers a comprehensive method for characterizing the arrhythmogenic substrate compared to solely anatomic evaluations. Article 3: Senolytic reduction of senescent cells mitigates atrial arrhythmia vulnerability in aging rabbits. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41513056 Summary: The study found that senolytic reduction of senescent cells effectively mitigated atrial arrhythmia vulnerability in aging rabbits. Cellular senescence contributes to age-related atrial fibrillation pathogenesis through its senescence-associated secretory phenotype, releasing proinflammatory and profibrotic factors. This research demonstrates a novel therapeutic strategy for age-related atrial arrhythmias by specifically targeting and reducing senescent cells. These findings indicate a direct link between cellular senescence and atrial fibrillation susceptibility in aging hearts. Article 4: Real-world performance of intrinsic antitachycardia pacing: Primary results from a global prospective postapproval registry study. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41500490 Summary: Intrinsic antitachycardia pacing (iATP) represents a closed-loop algorithm capable of automatically designing and adjusting antitachycardia pacing therapy in real time. This technology effectively prevents defibrillator shocks and associated adverse outcomes, particularly in cases of rapid monomorphic ventricular tachycardia. Real-world performance data demonstrated the operational capability of iATP in a large, global patient cohort equipped with iATP-enabled implantable cardioverter-defibrillators. This confirms iATP’s role in enhancing arrhythmia management by dynamically tailoring therapy. Article 5: Purkinje and septal substrate modification as a therapeutic option for patients with STEMI and refractory ventricular fibrillation. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41443487 Summary: The study described Purkinje and septal substrate modification using radiofrequency catheter ablation (R. F. C. A.) as a therapeutic option. This approach targets therapy-refractory ventricular fibrillation (V. F.) in patients after successful percutaneous coronary intervention (P. C. I.) for S. T.-elevation myocardial infarction (S. T. E. M. I.). Ventricular fibrillation remains a fatal complication in this patient population, highlighting the critical need for effective interventions. Modifying the Purkinje network and septal substrate offers a specific strategy to address this life-threatening arrhythmia. Transcript Today’s date is April 04, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Impact of left atrial posterior wall isolation using pulsed-field ablation in patients undergoing repeat catheter ablation for atrial fibrillation. For patients undergoing repeat catheter ablation for atrial fibrillation (AF), a therapeutic approach involves either redo pulmonary vein isolation (PVI) alone or combining redo PVI with adjunctive posterior wall isolation (PWI). The use of pulsed-field ablation (PFA) is a significant consideration for achieving durable isolation in these procedures. This strategy directly addresses the clinical challenge of recurrent atrial fibrillation by targeting both pulmonary veins and the posterior wall. The comparison of these two ablation strategies provides insights into optimizing outcomes in repeat atrial fibrillation interventions. Article number two. Comparison of combined anatomic and functional modeling with purely anatomic assessment in scar-dependent ventricular tachycardia. Identifying the critical substrate in scar-dependent ventricular tachycardia (VT) relies on precise mapping for ablation targets. Cardiac magnetic resonance imaging (M. R. I.) provides anatomic assessment (A. A.) to detect channels sustaining ventricular tachycardia. A refined approach involves heart digital twins, which integrate anatomic data with functional assessment for identifying the ventricular tachycardia isthmus. This combined anatomic and functional modeling offers a comprehensive method for characterizing the arrhythmogenic substrate compared to solely anatomic evaluations. Article number three. Senolytic reduction of senescent cells mitigates atrial arrhythmia vulnerability in aging rabbits. The study found that senolytic reduction of senescent cells effectively mitigated atrial arrhythmia vulnerability in aging rabbits. Cellular senescence contributes to age-related atrial fibrillation pathogenesis through its senescence-associated secretory phenotype, releasing proinflammatory and profibrotic factors. This research demonstrates a novel therapeutic strategy for age-related atrial arrhythmias by specifically targeting and reducing senescent cells. These findings indicate a direct link between cellular senescence and atrial fibrillation susceptibility in aging hearts. Article number four. Real-world performance of intrinsic antitachycardia pacing: Primary results from a global prospective postapproval registry study. Intrinsic antitachycardia pacing (iATP) represents a closed-loop algorithm capable of automatically designing and adjusting antitachycardia pacing therapy in real time. This technology effectively prevents defibrillator shocks and associated adverse outcomes, particularly in cases of rapid monomorphic ventricular tachycardia. Real-world performance data demonstrated the operational capability of iATP in a large, global patient cohort equipped with iATP-enabled implantable cardioverter-defibrillators. This confirms iATP’s role in enhancing arrhythmia management by dynamically tailoring therapy. Article number five. Purkinje and septal substrate modification as a therapeutic option for patients with STEMI and refractory ventricular fibrillation. The study described Purkinje and septal substrate modification using radiofrequency catheter ablation (R. F. C. A.) as a therapeutic option. This approach targets therapy-refractory ventricular fibrillation (V. F.) in patients after successful percutaneous coronary intervention (P. C. I.) for S. T.-elevation myocardial infarction (S. T. E. M. I.). Ventricular fibrillation remains a fatal complication in this patient population, highlighting the critical need for effective interventions. Modifying the Purkinje network and septal substrate offers a specific strategy to address this life-threatening arrhythmia. Thank you for listening. Don’t forget to subscribe. Keywords arrhythmia vulnerability, catheter ablation, S. T.-elevation myocardial infarction, pulmonary vein isolation, aging, heart digital twins, atrial fibrillation, antitachycardia pacing, cellular senescence, ventricular tachycardia, intrinsic antitachycardia pacing, pulsed-field ablation, posterior wall isolation, Purkinje network, cardiac magnetic resonance imaging, radiofrequency catheter ablation, anatomic assessment, senolytics, substrate mapping, ventricular fibrillation, arrhythmia management, septal substrate, implantable cardioverter-defibrillator. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Senolytics Prevent Atrial Arrhythmias in Elderly 04/04/26 first appea

Welcome to Cardiology Today – Recorded April 04, 2026. This episode summarizes 5 key cardiology studies on topics like Acetazolamide and Implantable Loop Recorders. Key takeaway: Bradyarrhythmias Reveal Stroke’s Atrial Link. Article Links: Article 1: Interhospital Transfer for Heart Failure in the United States: A Patient and Hospital-level Analysis from GWTG-HF. (Journal of cardiac failure) Article 2: Cardiac rehabilitation after transcatheter aortic valve implantation before, during and after the COVID-19 pandemic: a whole-population study. (Heart (British Cardiac Society)) Article 3: Acetazolamide Effects on Natriuresis and Diuresis in Acute Heart Failure Treated with Furosemide and SGLT2i (SANDI). (ESC heart failure) Article 4: Paced QRS Morphology and Lead Location in Left Bundle Branch Area Pacing Assessed by Photon-Counting Cardiac Computed Tomography. (Heart rhythm) Article 5: Prevalence of clinically significant bradyarrhythmias in patients implanted with loop recorders for cryptogenic stroke: A manifestation of atrial cardiomyopathy? (Heart rhythm) Full episode page: https://podcast.explainheart.com/podcast/bradyarrhythmias-reveal-strokes-atrial-link-04-04-26/ Featured Articles Article 1: Interhospital Transfer for Heart Failure in the United States: A Patient and Hospital-level Analysis from GWTG-HF. Journal: Journal of cardiac failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41932644 Summary: This study characterized patients with Heart Failure who underwent interhospital transfer, establishing their demographic and clinical profiles. It found significant variations in the utilization of interhospital transfer among different hospitals across the United States. The data revealed distinctions in outcomes between transferred and non-transferred Heart Failure patients. This analysis provided foundational understanding of interhospital transfer patterns in this patient population. Article 2: Cardiac rehabilitation after transcatheter aortic valve implantation before, during and after the COVID-19 pandemic: a whole-population study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41932822 Summary: This whole-population study established patterns of cardiac rehabilitation participation following Transcatheter Aortic Valve Implantation across England. It found variations in participation rates before, during, and after the C. O. V. I. D. minus 19 pandemic. The research demonstrated a specific association between cardiac rehabilitation participation and the primary outcome of unplanned all-cause rehospitalization. This analysis provided critical evidence regarding cardiac rehabilitation’s impact on clinical outcomes in this patient group. Article 3: Acetazolamide Effects on Natriuresis and Diuresis in Acute Heart Failure Treated with Furosemide and SGLT2i (SANDI). Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41920937 Summary: The S. A. N. D. I. study investigated the natriuretic and diuretic effects of acetazolamide in patients with acute Heart Failure receiving intravenous furosemide and concomitant Sodium-Glucose Cotransporter-two Inhibitors. It found that acetazolamide provided significant natriuretic and diuretic benefits in this specific patient population, demonstrating enhanced decongestion. This research established the efficacy of adjunctive acetazolamide in acute Heart Failure patients who are also on Sodium-Glucose Cotransporter-two Inhibitors, addressing a previously unknown therapeutic gap. Article 4: Paced QRS Morphology and Lead Location in Left Bundle Branch Area Pacing Assessed by Photon-Counting Cardiac Computed Tomography. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41932670 Summary: This study elucidated the relationship between intra-septal lead position in Left Bundle Branch Area Pacing and paced QRS morphology. It found that ultra-high-resolution Photon-Counting Computed Tomography precisely evaluated lead-tip location in 20 patients, differentiating between Left Bundle Branch Pacing, Left Ventricular Septal Pacing, and Deep Septal Pacing. The data established specific distances and spatial orientations of pacing leads within the septum, directly informing optimal lead placement strategies for physiological pacing. Article 5: Prevalence of clinically significant bradyarrhythmias in patients implanted with loop recorders for cryptogenic stroke: A manifestation of atrial cardiomyopathy? Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41519354 Summary: It found a notable burden of bradyarrhythmias in these patients compared with a matched control group. The data demonstrated that clinically significant bradyarrhythmias are a significant finding in this population, suggesting a potential manifestation of underlying atrial cardiomyopathy beyond Atrial Fibrillation detection. Transcript Today’s date is April 04, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Interhospital Transfer for Heart Failure in the United States: A Patient and Hospital-level Analysis from GWTG-HF. This study characterized patients with Heart Failure who underwent interhospital transfer, establishing their demographic and clinical profiles. It found significant variations in the utilization of interhospital transfer among different hospitals across the United States. The data revealed distinctions in outcomes between transferred and non-transferred Heart Failure patients. This analysis provided foundational understanding of interhospital transfer patterns in this patient population. Article number two. Cardiac rehabilitation after transcatheter aortic valve implantation before, during and after the COVID-19 pandemic: a whole-population study. This whole-population study established patterns of cardiac rehabilitation participation following Transcatheter Aortic Valve Implantation across England. It found variations in participation rates before, during, and after the C. O. V. I. D. minus 19 pandemic. The research demonstrated a specific association between cardiac rehabilitation participation and the primary outcome of unplanned all-cause rehospitalization. This analysis provided critical evidence regarding cardiac rehabilitation’s impact on clinical outcomes in this patient group. Article number three. Acetazolamide Effects on Natriuresis and Diuresis in Acute Heart Failure Treated with Furosemide and SGLT2i (SANDI). The S. A. N. D. I. study investigated the natriuretic and diuretic effects of acetazolamide in patients with acute Heart Failure receiving intravenous furosemide and concomitant Sodium-Glucose Cotransporter-two Inhibitors. It found that acetazolamide provided significant natriuretic and diuretic benefits in this specific patient population, demonstrating enhanced decongestion. This research established the efficacy of adjunctive acetazolamide in acute Heart Failure patients who are also on Sodium-Glucose Cotransporter-two Inhibitors, addressing a previously unknown therapeutic gap. Article number four. Paced QRS Morphology and Lead Location in Left Bundle Branch Area Pacing Assessed by Photon-Counting Cardiac Computed Tomography. This study elucidated the relationship between intra-septal lead position in Left Bundle Branch Area Pacing and paced QRS morphology. It found that ultra-high-resolution Photon-Counting Computed Tomography precisely evaluated lead-tip location in 20 patients, differentiating between Left Bundle Branch Pacing, Left Ventricular Septal Pacing, and Deep Septal Pacing. The data established specific distances and spatial orientations of pacing leads within the septum, directly informing optimal lead placement strategies for physiological pacing. Article number five. Prevalence of clinically significant bradyarrhythmias in patients implanted with loop recorders for cryptogenic stroke: A manifestation of atrial cardiomyopathy? This study established the prevalence and clinical significance of bradyarrhythmias in patients with cryptogenic stroke or transient ischemic attack who received implantable loop recorders. It found a notable burden of bradyarrhythmias in these patients compared with a matched control group. The data demonstrated that clinically significant bradyarrhythmias are a significant finding in this population, suggesting a potential manifestation of underlying atrial cardiomyopathy beyond Atrial Fibrillation detection. Thank you for listening. Don’t forget to subscribe. Keywords Acetazolamide, Implantable Loop Recorders, QRS Morphology, Hospital Variation, Sodium-Glucose Cotransporter-two Inhibitors, Heart Failure, Acute Heart Failure, Quality Improvement, Atrial Cardiomyopathy, Cardiac Rehabilitation, Transcatheter Aortic Valve Implantation, Atrial Fibrillation, Aortic Stenosis, Natriuresis, Left Bundle Branch Area Pacing, Cardiac Pacing, Photon-Counting Computed Tomography, Diuresis, Furosemide, Rehospitalization, Patient Outcomes, Interhospital Transfer, Cryptogenic Stroke, C. O. V. I. D. pandemic, Lead Placement, Bradyarrhythmias. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Bradyarrhythmias Reveal Stroke’s Atrial Link 04/04/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded April 03, 2026. This episode summarizes 5 key cardiology studies on topics like incident hypertension and quadruple guideline-directed medical therapies. Key takeaway: Glucagon-like Peptide-1 Agonists Cut Events Beyond Diabetes. Article Links: Article 1: Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity. (European heart journal) Article 2: Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 3: Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. (JAMA cardiology) Article 4: Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum. (JAMA cardiology) Article 5: Effect of Sildenafil on Platelet Activation and Mediators of Vascular Remodeling During LVAD Support. (ESC heart failure) Full episode page: https://podcast.explainheart.com/podcast/glucagon-like-peptide-1-agonists-cut-events-beyond-diabetes-04-03-26/ Featured Articles Article 1: Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41926331 Summary: Glucagon-like peptide-1 receptor agonists (G. L. P. minus 1 R. A.s) significantly reduced atherosclerosis burden and inflammatory biomarkers in experimental rabbit models. In clinical subjects, these agents decreased inflammatory biomarkers and major adverse cardiovascular events (MACE). These beneficial cardiovascular effects were observed irrespective of the patients’ glycemic status or obesity, indicating a direct cardiovascular protective mechanism. Article 2: Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40701206 Summary: A ten-minute asystolic warm ischemic time (A. W. I. T.) during donation after circulatory death (D. C. D.) heart recovery significantly predicted increased mortality in adult heart transplant recipients. This prolonged warm ischemic time was also associated with severe primary graft dysfunction. These findings specifically apply to cardiac allografts recovered using thoracoabdominal normothermic regional perfusion (N. R. P.). Article 3: Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41920552 Summary: The study characterized the time to quadruple guideline-directed medical therapies (G. D. M. T.s) following an initial diagnosis of heart failure with reduced ejection fraction (H. F. rEF). It identified specific factors associated with achieving timely initiation of these therapies in a large cohort of patients. The findings provide contemporary estimates on the duration and facilitators of initiating optimal quadruple therapy for patients with H. F. rEF. Article 4: Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41920533 Summary: The study found that genetic risk for high systolic blood pressure (S. B. P.) significantly stratified the risk of new-onset hypertension in women. This association was observed at two to seven years post partum. The genetic risk was an independent predictor, separate from women’s clinical characteristics and history of hypertensive disorders of pregnancy (H. D. P.), including preeclampsia, eclampsia, and gestational hypertension. Article 5: Effect of Sildenafil on Platelet Activation and Mediators of Vascular Remodeling During LVAD Support. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41926705 Summary: V. A. D. Support. Observational studies revealed an association between phosphodiesterase-5 inhibitors, specifically sildenafil, and lower mortality and ischemic stroke in patients undergoing durable left ventricular assist device (L. V. A. D.) support. This study conducted a double-blind, randomized, placebo-controlled investigation into sildenafil’s causal effects on platelet activation and circulating mediators of vascular remodeling. This research aims to understand the direct physiological impact of sildenafil that could explain its previously observed clinical benefits in this patient population. Transcript Today’s date is April 03, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity. Glucagon-like peptide-1 receptor agonists (G. L. P. minus 1 R. A.s) significantly reduced atherosclerosis burden and inflammatory biomarkers in experimental rabbit models. In clinical subjects, these agents decreased inflammatory biomarkers and major adverse cardiovascular events (MACE). These beneficial cardiovascular effects were observed irrespective of the patients’ glycemic status or obesity, indicating a direct cardiovascular protective mechanism. Article number two. Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion. A ten-minute asystolic warm ischemic time (A. W. I. T.) during donation after circulatory death (D. C. D.) heart recovery significantly predicted increased mortality in adult heart transplant recipients. This prolonged warm ischemic time was also associated with severe primary graft dysfunction. These findings specifically apply to cardiac allografts recovered using thoracoabdominal normothermic regional perfusion (N. R. P.). Article number three. Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. The study characterized the time to quadruple guideline-directed medical therapies (G. D. M. T.s) following an initial diagnosis of heart failure with reduced ejection fraction (H. F. rEF). It identified specific factors associated with achieving timely initiation of these therapies in a large cohort of patients. The findings provide contemporary estimates on the duration and facilitators of initiating optimal quadruple therapy for patients with H. F. rEF. Article number four. Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum. The study found that genetic risk for high systolic blood pressure (S. B. P.) significantly stratified the risk of new-onset hypertension in women. This association was observed at two to seven years post partum. The genetic risk was an independent predictor, separate from women’s clinical characteristics and history of hypertensive disorders of pregnancy (H. D. P.), including preeclampsia, eclampsia, and gestational hypertension. Article number five. Effect of Sildenafil on Platelet Activation and Mediators of Vascular Remodeling During L. V. A. D. Support. Observational studies revealed an association between phosphodiesterase-5 inhibitors, specifically sildenafil, and lower mortality and ischemic stroke in patients undergoing durable left ventricular assist device (L. V. A. D.) support. This study conducted a double-blind, randomized, placebo-controlled investigation into sildenafil’s causal effects on platelet activation and circulating mediators of vascular remodeling. This research aims to understand the direct physiological impact of sildenafil that could explain its previously observed clinical benefits in this patient population. Thank you for listening. Don’t forget to subscribe. Keywords incident hypertension, quadruple guideline-directed medical therapies, glucagon-like peptide-1 receptor agonists, post partum, normothermic regional perfusion, hypertensive disorders of pregnancy, genetic risk, blood pressure, vascular remodeling, time to therapy, sildenafil, cardiovascular events, donation after circulatory death, atherosclerosis, primary graft dysfunction, platelet activation, Veterans Health Administration, left ventricular assist device, liraglutide, heart transplant, inflammatory biomarkers, heart failure with reduced ejection fraction, asystolic warm ischemic time, morbidity, phosphodiesterase-5 inhibitors. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Glucagon-like Peptide-1 Agonists Cut Events Beyond Diabetes 04/03/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded April 02, 2026. This episode summarizes 5 key cardiology studies on topics like atrial fibrillation ablation and immature neutrophils. Key takeaway: Hypothermic Preservation Boosts Heart Transplant Survival. Article Links: Article 1: Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription. (European heart journal) Article 2: Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry. (European heart journal) Article 3: Immature neutrophils are elevated in human PGD and linked to G-CSF-driven injury in a murine model of lung ischemia-reperfusion. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 4: Impact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Improved 2-year heart transplant survival with moderate hypothermic donor heart preservation in the GUARDIAN heart registry. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Full episode page: https://podcast.explainheart.com/podcast/hypothermic-preservation-boosts-heart-transplant-survival-04-02-26/ Featured Articles Article 1: Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41920862 Summary: The Swedish Heart Failure Registry enabled a detailed assessment of patient adherence and persistence to quadruple pharmacotherapy for heart failure with reduced ejection fraction. This assessment confirmed the critical importance of patient adherence for the real-world uptake of these treatments. The study found specific associations between medication adherence and subsequent patient morbidity and mortality outcomes. Article 2: Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41914181 Summary: The E. M. B. O. L. minus A. F. Global Registry provided comprehensive data defining the incidence, outcomes, and procedural associations of stroke and systemic embolism following atrial fibrillation and left atrial flutter catheter ablation. This retrospective global registry captured detailed information from ablation centers worldwide, clarifying these previously poorly characterized complications. The registry’s findings illuminate critical insights into these post-ablation complications. Article 3: Immature neutrophils are elevated in human PGD and linked to G-CSF-driven injury in a murine model of lung ischemia-reperfusion. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41338428 Summary: This study found that immature neutrophils are elevated in human primary graft dysfunction. Researchers demonstrated a direct link between these immature neutrophils and granulocyte colony stimulating factor-driven injury in a murine model of lung ischemia-reperfusion. These findings indicate that immature neutrophils increase following lung transplantation and contribute to primary graft dysfunction severity. Article 4: Impact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41241030 Summary: This study found that infectious complications are common in patients implanted with HeartMate 3 left ventricular assist devices. The analysis specifically identified the impact of HeartMate 3 left ventricular assist device associated infection on outcomes following heart transplant. Researchers clarified crucial post-transplant outcomes by reviewing 115 patients with a HeartMate 3 device who underwent heart transplantation at Duke University Hospital. Article 5: Improved 2-year heart transplant survival with moderate hypothermic donor heart preservation in the GUARDIAN heart registry. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41241029 Summary: Data from the G. U. A. R. D. I. A. N. Heart Registry demonstrated improved two year heart transplant survival when using moderate hypothermic donor heart preservation. The Paragonix SherpaPak Cardiac Transport System, a method of static preservation, showed superior outcomes compared to historic ice storage. This study represents the first report of a preservation method demonstrating improved post-transplant survival. Transcript Today’s date is April 02, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription. The Swedish Heart Failure Registry enabled a detailed assessment of patient adherence and persistence to quadruple pharmacotherapy for heart failure with reduced ejection fraction. This assessment confirmed the critical importance of patient adherence for the real-world uptake of these treatments. The study found specific associations between medication adherence and subsequent patient morbidity and mortality outcomes. Article number two. Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry. The E. M. B. O. L. minus A. F. Global Registry provided comprehensive data defining the incidence, outcomes, and procedural associations of stroke and systemic embolism following atrial fibrillation and left atrial flutter catheter ablation. This retrospective global registry captured detailed information from ablation centers worldwide, clarifying these previously poorly characterized complications. The registry’s findings illuminate critical insights into these post-ablation complications. Article number three. Immature neutrophils are elevated in human PGD and linked to G-CSF-driven injury in a murine model of lung ischemia-reperfusion. This study found that immature neutrophils are elevated in human primary graft dysfunction. Researchers demonstrated a direct link between these immature neutrophils and granulocyte colony stimulating factor-driven injury in a murine model of lung ischemia-reperfusion. These findings indicate that immature neutrophils increase following lung transplantation and contribute to primary graft dysfunction severity. Article number four. Impact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant. This study found that infectious complications are common in patients implanted with HeartMate 3 left ventricular assist devices. The analysis specifically identified the impact of HeartMate 3 left ventricular assist device associated infection on outcomes following heart transplant. Researchers clarified crucial post-transplant outcomes by reviewing 115 patients with a HeartMate 3 device who underwent heart transplantation at Duke University Hospital. Article number five. Improved two year heart transplant survival with moderate hypothermic donor heart preservation in the GUARDIAN heart registry. Data from the G. U. A. R. D. I. A. N. Heart Registry demonstrated improved two year heart transplant survival when using moderate hypothermic donor heart preservation. The Paragonix SherpaPak Cardiac Transport System, a method of static preservation, showed superior outcomes compared to historic ice storage. This study represents the first report of a preservation method demonstrating improved post-transplant survival. Thank you for listening. Don’t forget to subscribe. Keywords atrial fibrillation ablation, immature neutrophils, HeartMate 3, G. U. A. R. D. I. A. N. Heart Registry, granulocyte colony stimulating factor, stroke, lung transplantation, hypothermic preservation, lung ischemia-reperfusion injury, catheter ablation, Paragonix SherpaPak, primary graft dysfunction, left ventricular assist device infection, heart transplant survival, patient persistence, morbidity, mortality, donor heart, infectious complications, heart transplant outcomes, heart failure with reduced ejection fraction, pharmacotherapy adherence, Duke University Hospital, left atrial flutter, systemic embolism. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Hypothermic Preservation Boosts Heart Transplant Survival 04/02/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded April 01, 2026. This episode summarizes 5 key cardiology studies on topics like estimated glomerular filtration rate and chronic kidney disease. Key takeaway: APOC3 Inhibition Cuts Lipids 70 Percent. Article Links: Article 1: Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study. (Circulation) Article 2: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study. (Circulation) Article 3: Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN STEMI Randomized Controlled Trial. (Circulation) Article 4: The Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Non-Inferiority Randomized Trial. (Circulation) Article 5: Pre-heart failure in early chronic kidney disease: clinical epidemiology and treatment. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/apoc3-inhibition-cuts-lipids-70-percent-04-01-26/ Featured Articles Article 1: Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41919388 Summary: Suboptimal cardiovascular-kidney-metabolic health is highly prevalent among older adults in the United States. The American Heart Association has developed a Cardiovascular-Kidney-Metabolic syndrome staging framework to categorize risk. Despite this framework, its predictive utility for incident heart failure remains an area of uncertainty in this population. Understanding the relationship between Cardiovascular-Kidney-Metabolic syndrome stages, echocardiographic characteristics, and heart failure risk is essential for clinical management. Article 2: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910513 Summary: P. O. C. 3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-T. I. M. I. 73b Imaging Study. Olezarsen, an antisense oligonucleotide inhibiting apolipoprotein C-III, reduces triglycerides by approximately 60 percent and remnant cholesterol by approximately 70 percent. This treatment also decreases apolipoprotein B by approximately 15 percent, while maintaining a neutral effect on low-density lipoprotein cholesterol in patients with moderate hypertriglyceridemia. These observed lipid modifications suggest a therapeutic approach to address triglyceride-rich lipoproteins and remnant cholesterol. Such inhibition holds significant clinical interest for its potential impact on coronary atherosclerosis. Article 3: Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN STEMI Randomized Controlled Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910504 Summary: T.-Elevation Myocardial Infarction Undergoing Primary P. C. I.: H. E. P. A. R. I. N. S. T. E. M. I. Randomized Controlled Trial. Primary percutaneous coronary intervention is the preferred reperfusion strategy for patients with S. T.-elevation myocardial infarction. The benefits and safety of administering unfractionated heparin in the prehospital setting for these patients remain a critical clinical question. Optimizing pretreatment strategies with agents like unfractionated heparin at first medical contact is important for patients undergoing primary percutaneous coronary intervention. Investigating the efficacy and safety of such prehospital interventions informs best practices for acute myocardial infarction management. Article 4: The Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Non-Inferiority Randomized Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910411 Summary: The role of atrial pacing support in cardiac resynchronization therapy-defibrillator patients without sinus node dysfunction is a clinically relevant question. Simplified cardiac resynchronization therapy-defibrillator systems that offer atrial sensing without full pacing support via a two-lead system could reduce procedural complexity. Determining if a two-lead system is non-inferior to a conventional three-lead system is important for patient selection and device choice. Evaluating these systems helps optimize outcomes and minimize risks associated with device implantation for cardiac resynchronization therapy. Article 5: Pre-heart failure in early chronic kidney disease: clinical epidemiology and treatment. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41914187 Summary: Chronic kidney disease affects 10 percent to 15 percent of adults globally and serves as a powerful, independent risk factor for cardiovascular diseases, including heart failure. Early stages of chronic kidney disease, specifically stages G1 to G3, are significantly associated with this elevated risk. The presence of albuminuria, particularly K. D. I. G. O. stages A2 to A3, further exacerbates cardiovascular risk even with mild renal dysfunction. These findings underscore the importance of recognizing pre-heart failure states in chronic kidney disease patients to inform early intervention strategies. Transcript Today’s date is April 01, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study. Suboptimal cardiovascular-kidney-metabolic health is highly prevalent among older adults in the United States. The American Heart Association has developed a Cardiovascular-Kidney-Metabolic syndrome staging framework to categorize risk. Despite this framework, its predictive utility for incident heart failure remains an area of uncertainty in this population. Understanding the relationship between Cardiovascular-Kidney-Metabolic syndrome stages, echocardiographic characteristics, and heart failure risk is essential for clinical management. Article number two. Effect of A. P. O. C. 3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-T. I. M. I. 73b Imaging Study. Olezarsen, an antisense oligonucleotide inhibiting apolipoprotein C-III, reduces triglycerides by approximately 60 percent and remnant cholesterol by approximately 70 percent. This treatment also decreases apolipoprotein B by approximately 15 percent, while maintaining a neutral effect on low-density lipoprotein cholesterol in patients with moderate hypertriglyceridemia. These observed lipid modifications suggest a therapeutic approach to address triglyceride-rich lipoproteins and remnant cholesterol. Such inhibition holds significant clinical interest for its potential impact on coronary atherosclerosis. Article number three. Prehospital Heparin Administration in Patients With S. T.-Elevation Myocardial Infarction Undergoing Primary P. C. I.: H. E. P. A. R. I. N. S. T. E. M. I. Randomized Controlled Trial. Primary percutaneous coronary intervention is the preferred reperfusion strategy for patients with S. T.-elevation myocardial infarction. The benefits and safety of administering unfractionated heparin in the prehospital setting for these patients remain a critical clinical question. Optimizing pretreatment strategies with agents like unfractionated heparin at first medical contact is important for patients undergoing primary percutaneous coronary intervention. Investigating the efficacy and safety of such prehospital interventions informs best practices for acute myocardial infarction management. Article number four. The Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Non-Inferiority Randomized Trial. The role of atrial pacing support in cardiac resynchronization therapy-defibrillator patients without sinus node dysfunction is a clinically relevant question. Simplified cardiac resynchronization therapy-defibrillator systems that offer atrial sensing without full pacing support via a two-lead system could reduce procedural complexity. Determining if a two-lead system is non-inferior to a conventional three-lead system is important for patient selection and device choice. Evaluating these systems helps optimize outcomes and minimize risks associated with device implantation for cardiac resynchronization therapy. Article number five. Pre-heart failure in early chronic kidney disease: clinical epidemiology and treatment. Chronic kidney disease affects 10 percent to 15 percent of adults globally and serves as a powerful, independent risk factor for cardiovascular diseases, including heart failure. Early stages of chronic kidney disease, specifically stages G1 to G3, are significantly associated with this elevated risk. The presence of albuminuria, particularly K. D. I. G. O. stages A2 to A3, further exacerbates cardiovascular risk even with mild renal dysfunction. These findings underscore the importance of recognizing pre-heart failure states in chronic kidney disease patients to inform early intervention strategies. Thank you for listening. Don’t forget to subscribe. Keywords estimated glomerular filtration rate, chronic kidney disease, prehospital care, S. T.-elevation myocardial infarction, unfractionated heparin, three-lead system, defibrillator, apolipoprotein C-III inhibition, CKM staging framework, cardiovascular risk, remnant cholesterol, cardiac resynchronization therapy, albuminuria, Atherosclerosis Risk in Communities Study, primary percutaneous coronary intervention, heart failure, olezarsen, atrial pacing, two-lead system, echocardiography, acute myocardial infarction, cardiovascular-kidney-metabolic syndrome, hypertriglyceridemia, triglycerides. About Concise summaries of cardiovascular research for professionals. Subscribe • Shar

Welcome to Cardiology Today – Recorded April 01, 2026. This episode summarizes 5 key cardiology studies on topics like high-risk P. C. I. and mid-regional pro-adrenomedullin. Key takeaway: Adaptive A. I. Validates C. V. Event Adjudication. Article Links: Article 1: Angiography-Based Physiology to Guide Coronary Revascularization. (The New England journal of medicine) Article 2: Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention. (The New England journal of medicine) Article 3: IVUS or Angiography Guidance for Percutaneous Coronary Intervention in Complex Coronary Bifurcation Lesions: The DKCRUSH VIII Randomized Clinical Trial. (Journal of the American College of Cardiology) Article 4: MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis. (Circulation) Article 5: Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials. (Circulation) Full episode page: https://podcast.explainheart.com/podcast/adaptive-a-i-validates-c-v-event-adjudication-04-01-26/ Featured Articles Article 1: Angiography-Based Physiology to Guide Coronary Revascularization. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910382 Summary: This international, randomized, noninferiority trial directly compared angiography-derived vessel fractional flow reserve (vFFR) with pressure-wire based fractional flow reserve (FFR) for guiding coronary revascularization. The trial evaluated vFFR, a method derived from three-dimensional quantitative coronary angiography that does not require a pressure wire or hyperemic agent. It established a robust head-to-head comparison to assess the effectiveness and safety of this less invasive physiological guidance for intermediate coronary lesions. The study addressed a critical lack of data on angiography-based revascularization guidance compared to the established pressure-wire FFR technique. Article 2: Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910380 Summary: This randomized trial assigned 300 patients with severe left ventricular dysfunction and extensive coronary artery disease to a strategy of elective unloading with a microaxial flow pump or to standard care during planned complex percutaneous coronary intervention (P. C. I.). The study established a direct comparison to determine if percutaneous left ventricular unloading improves outcomes in this high-risk patient population. It specifically investigated the impact of prophylactic mechanical support via a microaxial flow pump on mortality and complications during complex revascularization. This trial provides crucial data on the efficacy of a dedicated left ventricular unloading strategy in patients undergoing high-risk P. C. I. Article 3: IVUS or Angiography Guidance for Percutaneous Coronary Intervention in Complex Coronary Bifurcation Lesions: The DKCRUSH VIII Randomized Clinical Trial. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41914946 Summary: V. U. S. or Angiography Guidance for Percutaneous Coronary Intervention in Complex Coronary Bifurcation Lesions: The D. K. C. R. U. S. H. VIII Randomized Clinical Trial. Intravascular ultrasound (I. V. U. S.)-guided percutaneous coronary intervention (P. C. I.) is associated with fewer clinical events than angiography-guided P. C. I. The D. K. C. R. U. S. H. eight randomized clinical trial directly investigated the treatment effect of I. V. U. S.-guided P. C. I. compared to angiography-guided P. C. I. in patients with complex coronary bifurcation lesions undergoing double kissing crush stenting. This study established a head-to-head comparison to determine if I. V. U. S. guidance improves outcomes in this specific, challenging patient subgroup. It provides definitive evidence for the optimal guidance strategy in complex coronary bifurcation lesions treated with double kissing crush. Article 4: MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41914183 Summary: R. – ProA. D. M. Predicts Mortality and Heart Failure Events in A. T. T. R. Cardiac Amyloidosis. This study evaluated the prognostic value of 12 different circulating biomarkers for predicting outcomes in transthyretin amyloid cardiomyopathy (A. T. T. R. – C. M.). The assessed biomarkers included N-terminal pro-B-type natriuretic peptide (N. T. – proB. N. P.), high-sensitivity troponin I (hsTnI), and mid-regional pro-adrenomedullin (M. R. – proA. D. M.). The research specifically investigated tools for risk and prognosis stratification in A. T. T. R. – C. M. patients, addressing a growing clinical demand due to earlier diagnoses and new therapeutic options. This evaluation provides a comprehensive assessment of biomarker utility in identifying patient risk for future events in this disease. Article 5: Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41911340 Summary: I. for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the O. D. Y. S. S. E. Y. O. U. T. C. O. M. E. S. and E. U. C. L. I. D. Trials. Researchers developed and validated A. D. A. P. T. – C. E. C., an artificial intelligence (A. I.) algorithm capable of adjudicating multiple cardiovascular endpoints and adapting to new definitions. The algorithm was derived using data on myocardial infarction (M. I.), stroke, and heart failure from the O. D. Y. S. S. E. Y. O. U. T. C. O. M. E. S. trial. A. D. A. P. T. – C. E. C. underwent external validation using M. I., stroke, bleeding, and cardiovascular (C. V.) death data from the E. U. C. L. I. D. trial, demonstrating its performance across different clinical definitions. This innovative A. I. solution provides an adaptive, automated method for C. V. endpoint measurement in clinical trials, offering potential reductions in time and cost. Transcript Today’s date is April 01, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Angiography-Based Physiology to Guide Coronary Revascularization. This international, randomized, noninferiority trial directly compared angiography-derived vessel fractional flow reserve (vFFR) with pressure-wire based fractional flow reserve (FFR) for guiding coronary revascularization. The trial evaluated vFFR, a method derived from three-dimensional quantitative coronary angiography that does not require a pressure wire or hyperemic agent. It established a robust head-to-head comparison to assess the effectiveness and safety of this less invasive physiological guidance for intermediate coronary lesions. The study addressed a critical lack of data on angiography-based revascularization guidance compared to the established pressure-wire FFR technique. Article number two. Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention. This randomized trial assigned 300 patients with severe left ventricular dysfunction and extensive coronary artery disease to a strategy of elective unloading with a microaxial flow pump or to standard care during planned complex percutaneous coronary intervention (P. C. I.). The study established a direct comparison to determine if percutaneous left ventricular unloading improves outcomes in this high-risk patient population. It specifically investigated the impact of prophylactic mechanical support via a microaxial flow pump on mortality and complications during complex revascularization. This trial provides crucial data on the efficacy of a dedicated left ventricular unloading strategy in patients undergoing high-risk P. C. I. Article number three. I. V. U. S. or Angiography Guidance for Percutaneous Coronary Intervention in Complex Coronary Bifurcation Lesions: The D. K. C. R. U. S. H. VIII Randomized Clinical Trial. Intravascular ultrasound (I. V. U. S.)-guided percutaneous coronary intervention (P. C. I.) is associated with fewer clinical events than angiography-guided P. C. I. The D. K. C. R. U. S. H. eight randomized clinical trial directly investigated the treatment effect of I. V. U. S.-guided P. C. I. compared to angiography-guided P. C. I. in patients with complex coronary bifurcation lesions undergoing double kissing crush stenting. This study established a head-to-head comparison to determine if I. V. U. S. guidance improves outcomes in this specific, challenging patient subgroup. It provides definitive evidence for the optimal guidance strategy in complex coronary bifurcation lesions treated with double kissing crush. Article number four. M. R. – ProA. D. M. Predicts Mortality and Heart Failure Events in A. T. T. R. Cardiac Amyloidosis. This study evaluated the prognostic value of 12 different circulating biomarkers for predicting outcomes in transthyretin amyloid cardiomyopathy (A. T. T. R. – C. M.). The assessed biomarkers included N-terminal pro-B-type natriuretic peptide (N. T. – proB. N. P.), high-sensitivity troponin I (hsTnI), and mid-regional pro-adrenomedullin (M. R. – proA. D. M.). The research specifically investigated tools for risk and prognosis stratification in A. T. T. R. – C. M. patients, addressing a growing clinical demand due to earlier diagnoses and new therapeutic options. This evaluation provides a comprehensive assessment of biomarker utility in identifying patient risk for future events in this disease. Article number five. Adaptive A. I. for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the O. D. Y. S. S. E. Y. O. U. T. C. O. M. E. S. and E. U. C. L. I. D. Trials

Welcome to Cardiology Today – Recorded March 31, 2026. This episode summarizes 5 key cardiology studies on topics like heart failure and intermediate coronary lesions. Key takeaway: Mavacamten Targets Adolescent H. C. M.. Article Links: Article 1: IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease. (The New England journal of medicine) Article 2: Intravascular Ultrasound-Guided or Angiography-Guided Complex High-Risk PCI. (The New England journal of medicine) Article 3: Discontinuation of Beta-Blocker Therapy after Myocardial Infarction. (The New England journal of medicine) Article 4: Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy. (The New England journal of medicine) Article 5: Angiography-Derived Fractional Flow Reserve to Guide PCI. (The New England journal of medicine) Full episode page: https://podcast.explainheart.com/podcast/mavacamten-targets-adolescent-h-c-m-03-31-26/ Featured Articles Article 1: IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41911017 Summary: Percutaneous coronary intervention for unprotected left main coronary artery disease is a critical revascularization strategy in cardiology. The comparative effectiveness of intravascular ultrasonographic guidance versus conventional angiographic guidance in improving clinical outcomes for P. C. I. remains an area of active investigation. Clarifying the optimal guidance method holds significant implications for patient prognosis in this high-risk population. Article 2: Intravascular Ultrasound-Guided or Angiography-Guided Complex High-Risk PCI. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41911016 Summary: Intravascular ultrasonography guidance during percutaneous coronary intervention has been associated with increased stent optimization and reduced adverse events in patients with complex coronary artery lesions. Despite these recognized benefits and practice guideline recommendations for intracoronary imaging in anatomically complex lesions, adoption of this strategy in Western countries remains low. This highlights an ongoing need for robust evidence supporting its broader clinical integration in high-risk P. C. I. procedures. Article 3: Discontinuation of Beta-Blocker Therapy after Myocardial Infarction. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910427 Summary: The long-term role of beta-blocker therapy after a myocardial infarction is currently undefined for patients with preserved left ventricular systolic function and without heart failure, particularly in the era of modern reperfusion and secondary prevention. This clinical uncertainty impacts decisions regarding medication continuation for stable post-myocardial infarction patients. Resolving this question has substantial implications for reducing polypharmacy and tailoring post-event care. Article 4: Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910394 Summary: Approved pharmacologic therapies for pediatric hypertrophic cardiomyopathy are currently lacking, often leading to surgical intervention for left ventricular outflow tract obstruction. Mavacamten, a cardiac myosin inhibitor, is an established treatment for adults with obstructive hypertrophic cardiomyopathy. Evaluating the efficacy and safety of mavacamten in symptomatic adolescents with this condition addresses a critical unmet therapeutic need for younger patients. Article 5: Angiography-Derived Fractional Flow Reserve to Guide PCI. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41910384 Summary: Physiological assessment of intermediate coronary lesions using an intracoronary pressure wire demonstrably improves clinical outcomes for patients undergoing cardiac catheterization and percutaneous coronary intervention. However, the widespread clinical adoption of pressure-wire-based physiological assessment remains limited. Angiography-derived fractional flow reserve shows good correlation with pressure-wire-based measurements and can simplify procedures, but its definitive impact on patient clinical outcomes remains unestablished. Transcript Today’s date is March 31, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease. Percutaneous coronary intervention for unprotected left main coronary artery disease is a critical revascularization strategy in cardiology. The comparative effectiveness of intravascular ultrasonographic guidance versus conventional angiographic guidance in improving clinical outcomes for P. C. I. remains an area of active investigation. Clarifying the optimal guidance method holds significant implications for patient prognosis in this high-risk population. Article number two. Intravascular Ultrasound-Guided or Angiography-Guided Complex High-Risk PCI. Intravascular ultrasonography guidance during percutaneous coronary intervention has been associated with increased stent optimization and reduced adverse events in patients with complex coronary artery lesions. Despite these recognized benefits and practice guideline recommendations for intracoronary imaging in anatomically complex lesions, adoption of this strategy in Western countries remains low. This highlights an ongoing need for robust evidence supporting its broader clinical integration in high-risk P. C. I. procedures. Article number three. Discontinuation of Beta-Blocker Therapy after Myocardial Infarction. The long-term role of beta-blocker therapy after a myocardial infarction is currently undefined for patients with preserved left ventricular systolic function and without heart failure, particularly in the era of modern reperfusion and secondary prevention. This clinical uncertainty impacts decisions regarding medication continuation for stable post-myocardial infarction patients. Resolving this question has substantial implications for reducing polypharmacy and tailoring post-event care. Article number four. Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy. Approved pharmacologic therapies for pediatric hypertrophic cardiomyopathy are currently lacking, often leading to surgical intervention for left ventricular outflow tract obstruction. Mavacamten, a cardiac myosin inhibitor, is an established treatment for adults with obstructive hypertrophic cardiomyopathy. Evaluating the efficacy and safety of mavacamten in symptomatic adolescents with this condition addresses a critical unmet therapeutic need for younger patients. Article number five. Angiography-Derived Fractional Flow Reserve to Guide PCI. Physiological assessment of intermediate coronary lesions using an intracoronary pressure wire demonstrably improves clinical outcomes for patients undergoing cardiac catheterization and percutaneous coronary intervention. However, the widespread clinical adoption of pressure-wire-based physiological assessment remains limited. Angiography-derived fractional flow reserve shows good correlation with pressure-wire-based measurements and can simplify procedures, but its definitive impact on patient clinical outcomes remains unestablished. Thank you for listening. Don’t forget to subscribe. Keywords heart failure, intermediate coronary lesions, beta-blocker therapy, stent optimization, cardiac myosin inhibitor, angiography, percutaneous coronary intervention, adolescents, pressure-wire assessment, complex coronary artery lesions, unprotected left main coronary artery disease, adverse events, angiography-derived F. F. R., left ventricular systolic function, mavacamten, intravascular ultrasonography, hypertrophic cardiomyopathy, fractional flow reserve, left ventricular outflow tract obstruction, myocardial infarction, secondary prevention, clinical outcomes. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Mavacamten Targets Adolescent H. C. M. 03/31/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded March 30, 2026. This episode summarizes 5 key cardiology studies on topics like Cardiovascular Disease and Imaging. Key takeaway: AI Democratizes Congenital Heart Disease Echo. Article Links: Article 1: Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study. (Circulation) Article 2: Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men. (Circulation) Article 3: Automated Echocardiographic Detection of Congenital Heart Disease Using Artificial Intelligence. (Circulation) Article 4: Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. (European heart journal) Article 5: Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/ai-democratizes-congenital-heart-disease-echo-03-30-26/ Featured Articles Article 1: Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41904795 Summary: Combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction is a condition carrying significant mortality for which no proven therapies exist. The phase two randomized CADENCE study evaluated sotatercept as a potential treatment, administered at 0.3 or 0.7 milligrams per kilogram, or placebo, every three weeks. The primary endpoint measured was the change in pulmonary vascular resistance at week twenty-four. Article 2: Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41903131 Summary: Myocardial infarction with non-obstructive coronary arteries presents with various underlying causes, often including mimicking conditions, despite imaging recommendations to identify etiologies. This international, prospective study characterized the mechanisms of myocardial infarction with non-obstructive coronary arteries, analyzed predictors of imaging abnormalities, and explored sex differences. Article 3: Automated Echocardiographic Detection of Congenital Heart Disease Using Artificial Intelligence. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41902792 Summary: Delayed or missed diagnosis of congenital heart disease significantly contributes to pediatric mortality worldwide. Expert echocardiography interpretation, which is central to diagnosing and triaging congenital heart disease, represents a scarce and maldistributed global resource. This study developed EchoFocus-C. H. D., an artificial intelligence-enabled tool designed to democratize diagnostics and extend expert-level interpretation beyond large academic centers. Article 4: Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41905344 Summary: Vigorous physical activity is known to provide greater health benefits per unit time than moderate activity, yet the full spectrum of these benefits across chronic diseases and the relative importance of intensity versus volume remains unclear. A prospective population-based cohort study of 96408 participants examined associations between the proportion of vigorous physical activity relative to total physical activity volume and the incidence of multiple chronic disease outcomes. Article 5: Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41903523 Summary: Elevated lipoprotein(a) levels are an established risk factor for atherosclerotic cardiovascular disease, however, its association with venous thromboembolism remains unclear, with potential modification by sex and hormonal status. This study investigated this relationship using participants from the U. K. Biobank with baseline lipoprotein(a) data. The study design excluded individuals with a history of venous thromboembolism or cancer, as well as those using anticoagulants. Transcript Today’s date is March 30, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study. Combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction is a condition carrying significant mortality for which no proven therapies exist. The phase two randomized CADENCE study evaluated sotatercept as a potential treatment, administered at 0.3 or 0.7 milligrams per kilogram, or placebo, every three weeks. The primary endpoint measured was the change in pulmonary vascular resistance at week twenty-four. Article number two. Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men. Myocardial infarction with non-obstructive coronary arteries presents with various underlying causes, often including mimicking conditions, despite imaging recommendations to identify etiologies. This international, prospective study characterized the mechanisms of myocardial infarction with non-obstructive coronary arteries, analyzed predictors of imaging abnormalities, and explored sex differences. Article number three. Automated Echocardiographic Detection of Congenital Heart Disease Using Artificial Intelligence. Delayed or missed diagnosis of congenital heart disease significantly contributes to pediatric mortality worldwide. Expert echocardiography interpretation, which is central to diagnosing and triaging congenital heart disease, represents a scarce and maldistributed global resource. This study developed EchoFocus-C. H. D., an artificial intelligence-enabled tool designed to democratize diagnostics and extend expert-level interpretation beyond large academic centers. Article number four. Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. Vigorous physical activity is known to provide greater health benefits per unit time than moderate activity, yet the full spectrum of these benefits across chronic diseases and the relative importance of intensity versus volume remains unclear. A prospective population-based cohort study of 96408 participants examined associations between the proportion of vigorous physical activity relative to total physical activity volume and the incidence of multiple chronic disease outcomes. Article number five. Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in men. Elevated lipoprotein(a) levels are an established risk factor for atherosclerotic cardiovascular disease, however, its association with venous thromboembolism remains unclear, with potential modification by sex and hormonal status. This study investigated this relationship using participants from the U. K. Biobank with baseline lipoprotein(a) data. The study design excluded individuals with a history of venous thromboembolism or cancer, as well as those using anticoagulants. Thank you for listening. Don’t forget to subscribe. Keywords Cardiovascular Disease, Imaging, EchoFocus-C. H. D., Sotatercept, Pediatric Mortality, Artificial Intelligence, Atherosclerotic Cardiovascular Disease, Combined Post- and Pre-capillary Pulmonary Hypertension, Lipoprotein(a), Sex Differences, Physical Activity, Vigorous Physical Activity, Phase two trial, Physical Activity Intensity, Echocardiography, Physical Activity Volume, Congenital Heart Disease, Myocardial Infarction with Non-Obstructive Coronary Arteries, Hormonal Status, Chronic Diseases, Heart Failure with Preserved Ejection Fraction, Venous Thromboembolism, Predictors, Pulmonary Vascular Resistance, Etiologies. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post AI Democratizes Congenital Heart Disease Echo 03/30/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded March 29, 2026. This episode summarizes 5 key cardiology studies on topics like Cardiomyopathy and Excess mortality. Key takeaway: Neurovascular Retinomics Predicts Heart Disease. Article Links: Article 1: Effect of age on 5-year excess mortality in heart failure with reduced ejection fraction. (European journal of heart failure) Article 2: Neurovascular retinomics for predicting heart diseases. (Cardiovascular research) Article 3: A randomized, double-blind, crossover study of acute low-level night-time road traffic noise: effects on vascular function, sleep, and proteomic signatures in healthy adults. (Cardiovascular research) Article 4: Sodium-myo-inositol cotransporter-1, SMIT1, promotes cardiac hypertrophy and fibrosis induced by pressure overload in mice. (Cardiovascular research) Article 5: Cardiomyocyte-specific deficiency of C/EBPβ aggravates pressure overload-induced heart failure. (Cardiovascular research) Full episode page: https://podcast.explainheart.com/podcast/neurovascular-retinomics-predicts-heart-disease-03-29-26/ Featured Articles Article 1: Effect of age on 5-year excess mortality in heart failure with reduced ejection fraction. Journal: European journal of heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41889326 Summary: The abstract outlines a significant research study focused on the impact of age on 5-year excess mortality in Heart Failure with Reduced Ejection Fraction. This investigation includes patients aged 40 to 85 years, all presenting with a left ventricular ejection fraction of 40 percent or less, who underwent coronary angiography for suspected cardiomyopathy. The methodology involves matching patients by sex and age, thus characterizing a structured approach to understand age-related differences in survival outcomes. This research addresses a crucial gap in current understanding of age as a determinant of prognosis in Heart Failure with Reduced Ejection Fraction. Article 2: Neurovascular retinomics for predicting heart diseases. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41748319 Summary: The abstract describes a comprehensive methodology developed for utilizing neurovascular retinomics to predict incident heart diseases. This approach integrates multidimensional vascular parameters from color fundus photography with neural parameters obtained from optical coherence tomography. The study design incorporated LASSO regression for meticulous feature selection and employed a Gradient Boosting Machine model to assess predictive value. This framework characterizes a specific computational strategy for leveraging retinal imaging data in cardiovascular risk evaluation. Article 3: A randomized, double-blind, crossover study of acute low-level night-time road traffic noise: effects on vascular function, sleep, and proteomic signatures in healthy adults. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41740584 Summary: The abstract presents a randomized, double-blind, crossover study that investigated the acute effects of low-level night-time road traffic noise on vascular function, sleep, and proteomic signatures in healthy adults. The research design exposed 74 healthy participants to three distinct overnight conditions, including a control with no noise and specific levels of road traffic noise. This structured methodology forms a basis for generating direct mechanistic evidence regarding environmental noise as a cardiovascular risk factor. The study provides a rigorous approach for evaluating acute physiological responses to noise exposure in humans. Article 4: Sodium-myo-inositol cotransporter-1, SMIT1, promotes cardiac hypertrophy and fibrosis induced by pressure overload in mice. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41698873 Summary: The abstract highlights the emerging role of myo-inositol, which is consistently elevated in plasma of patients with Heart Failure, as a significant area of research in cardiac dysfunction. It details the function of sodium-myo-inositol co-transporter-1, or S. M. I. T. 1., a member of the sodium-glucose co-transporter family specifically expressed in the heart, in myo-inositol transport. The research described addresses the poorly understood mechanism by which myo-inositol dysregulation contributes to cardiac dysfunction. This investigation focuses on understanding the molecular pathways involving S. M. I. T. 1. in the context of heart failure. Article 5: Cardiomyocyte-specific deficiency of C/EBPβ aggravates pressure overload-induced heart failure. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41618689 Summary: The abstract introduces CCAAT/enhancer-binding protein beta, a transcription factor known for regulating cell processes including inflammation, as a significant area of cardiac research. It identifies a critical gap in understanding the cell-type-specific functions of C. E. B. P. beta in the heart during stress and baseline conditions. The described investigation focuses on clarifying the role of endogenous C. E. B. P. beta specifically within cardiomyocytes during pressure overload-induced heart failure. This research characterizes an effort to delineate the complex involvement of this protein in cardiac dysfunction. Transcript Today’s date is March 29, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Effect of age on 5-year excess mortality in heart failure with reduced ejection fraction. The abstract outlines a significant research study focused on the impact of age on 5-year excess mortality in Heart Failure with Reduced Ejection Fraction. This investigation includes patients aged 40 to 85 years, all presenting with a left ventricular ejection fraction of 40 percent or less, who underwent coronary angiography for suspected cardiomyopathy. The methodology involves matching patients by sex and age, thus characterizing a structured approach to understand age-related differences in survival outcomes. This research addresses a crucial gap in current understanding of age as a determinant of prognosis in Heart Failure with Reduced Ejection Fraction. Article number two. Neurovascular retinomics for predicting heart diseases. The abstract describes a comprehensive methodology developed for utilizing neurovascular retinomics to predict incident heart diseases. This approach integrates multidimensional vascular parameters from color fundus photography with neural parameters obtained from optical coherence tomography. The study design incorporated LASSO regression for meticulous feature selection and employed a Gradient Boosting Machine model to assess predictive value. This framework characterizes a specific computational strategy for leveraging retinal imaging data in cardiovascular risk evaluation. Article number three. A randomized, double-blind, crossover study of acute low-level night-time road traffic noise: effects on vascular function, sleep, and proteomic signatures in healthy adults. The abstract presents a randomized, double-blind, crossover study that investigated the acute effects of low-level night-time road traffic noise on vascular function, sleep, and proteomic signatures in healthy adults. The research design exposed 74 healthy participants to three distinct overnight conditions, including a control with no noise and specific levels of road traffic noise. This structured methodology forms a basis for generating direct mechanistic evidence regarding environmental noise as a cardiovascular risk factor. The study provides a rigorous approach for evaluating acute physiological responses to noise exposure in humans. Article number four. Sodium-myo-inositol cotransporter-1, SMIT1, promotes cardiac hypertrophy and fibrosis induced by pressure overload in mice. The abstract highlights the emerging role of myo-inositol, which is consistently elevated in plasma of patients with Heart Failure, as a significant area of research in cardiac dysfunction. It details the function of sodium-myo-inositol co-transporter-1, or S. M. I. T. 1., a member of the sodium-glucose co-transporter family specifically expressed in the heart, in myo-inositol transport. The research described addresses the poorly understood mechanism by which myo-inositol dysregulation contributes to cardiac dysfunction. This investigation focuses on understanding the molecular pathways involving S. M. I. T. 1. in the context of heart failure. Article number five. Cardiomyocyte-specific deficiency of C/EBPβ aggravates pressure overload-induced heart failure. The abstract introduces CCAAT/enhancer-binding protein beta, a transcription factor known for regulating cell processes including inflammation, as a significant area of cardiac research. It identifies a critical gap in understanding the cell-type-specific functions of C. E. B. P. beta in the heart during stress and baseline conditions. The described investigation focuses on clarifying the role of endogenous C. E. B. P. beta specifically within cardiomyocytes during pressure overload-induced heart failure. This research characterizes an effort to delineate the complex involvement of this protein in cardiac dysfunction. Thank you for listening. Don’t forget to subscribe. Keywords Cardiomyopathy, Excess mortality, Heart diseases, Cardiomyocytes, Heart Failure with Reduced Ejection Fraction, Pressure overload, Cardiac fibrosis, Sleep, Color fundus photography, Vascular function, Age, Road traffic noise, CCAAT/enhancer-binding protein beta, Biomarker, Proteomic signatures, Heart failure, Transcription factor, Retinomics, Cardiac hypertrophy, Coronary angiography, Myo-inositol, Optical coherence tomography, Sodium-myo-inositol co-transporter-1, Cardiovascular risk factor. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Neurovascular Retin

Welcome to Cardiology Today – Recorded March 28, 2026. This episode summarizes 5 key cardiology studies on topics like heart failure and prognosis. Key takeaway: CAD Phenotypes Found for Tailored Prevention. Article Links: Article 1: Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study. (Heart (British Cardiac Society)) Article 2: Identifying clinical phenotype clusters in patients with coronary artery disease. (Heart (British Cardiac Society)) Article 3: Optimizing NT-proBNP Inclusion Cut-offs for Randomized Clinical Trials in Heart Failure: Data from the Swedish Heart Failure Registry. (ESC heart failure) Article 4: Role of Provocation and Exercise Imaging for the Identification of Candidates for Cardiac Myosin Inhibitors. (ESC heart failure) Article 5: Sex- and Phenotype-Specific Prognostic Implications of Body Mass Index in Acute Heart Failure. (ESC heart failure) Full episode page: https://podcast.explainheart.com/podcast/cad-phenotypes-found-for-tailored-prevention-03-28-26/ Featured Articles Article 1: Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40691042 Summary: A national cohort study of 852914 adult patients in England and Wales found that one-year all-cause mortality following acute myocardial infarction declined between 2005 and 2019. Researchers analyzed this 15-year dataset to quantify the contributions of clinical, treatment, and demographic factors to these changes. The findings provide crucial data for informing clinical strategies and health policy. Article 2: Identifying clinical phenotype clusters in patients with coronary artery disease. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40451277 Summary: This study found that clinical phenotype clusters exist in patients with coronary artery disease. Researchers used unsupervised machine learning through latent class analysis to identify these clusters. The study assessed the relationship of these identified phenotypes with the risk of recurrent cardiovascular events. This work addresses the need for specific considerations beyond current one-size-fits-all guideline recommendations for cardiovascular event prevention. Article 3: Optimizing NT-proBNP Inclusion Cut-offs for Randomized Clinical Trials in Heart Failure: Data from the Swedish Heart Failure Registry. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41894572 Summary: This study provided evidence-based guidance on selecting optimal N-terminal pro-B-type natriuretic peptide cut-offs for randomized controlled trials in heart failure. Researchers utilized data from the Swedish Heart Failure Registry, applying N-terminal pro-B-type natriuretic peptide cut-offs ranging from 200 to 5000 picograms per milliliter, which were derived from prior randomized controlled trials. The study calculated one-year incidence proportions to optimize the balance between event enrichment and screening failure across various heart failure subgroups. This optimizes patient selection for clinical trials, improving efficiency and relevance. Article 4: Role of Provocation and Exercise Imaging for the Identification of Candidates for Cardiac Myosin Inhibitors. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41885188 Summary: This study compared the characteristics and therapeutic response of patients with obstructive hypertrophic cardiomyopathy who only showed treatment-qualifying left ventricular outflow tract obstruction during exercise echocardiography, versus those who met eligibility at rest. Researchers assessed the therapeutic response to cardiac myosin inhibitors, specifically mavacamten, in these patient groups. The findings clarify the clinical profile and treatment response of patients who require exercise imaging to establish eligibility for these inhibitors. This work helps identify appropriate candidates for mavacamten therapy. Article 5: Sex- and Phenotype-Specific Prognostic Implications of Body Mass Index in Acute Heart Failure. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41885184 Summary: This study found that the prognostic implications of body mass index in patients with acute heart failure differed according to heart failure phenotype and sex. Researchers analyzed 5271 patients hospitalized for acute heart failure from the Korean Heart Failure three Registry. Body mass index was categorized into low, normal, and high groups using Asia-Pacific criteria. The primary outcome was a composite of two-year all-cause mortality or heart transplantation, showing varying risks across subgroups. Transcript Today’s date is March 28, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study. A national cohort study of 852914 adult patients in England and Wales found that one-year all-cause mortality following acute myocardial infarction declined between 2005 and 2019. Researchers analyzed this 15-year dataset to quantify the contributions of clinical, treatment, and demographic factors to these changes. The findings provide crucial data for informing clinical strategies and health policy. Article number two. Identifying clinical phenotype clusters in patients with coronary artery disease. This study found that clinical phenotype clusters exist in patients with coronary artery disease. Researchers used unsupervised machine learning through latent class analysis to identify these clusters. The study assessed the relationship of these identified phenotypes with the risk of recurrent cardiovascular events. This work addresses the need for specific considerations beyond current one-size-fits-all guideline recommendations for cardiovascular event prevention. Article number three. Optimizing N-terminal pro-B-type natriuretic peptide Inclusion Cut-offs for Randomized Clinical Trials in Heart Failure: Data from the Swedish Heart Failure Registry. This study provided evidence-based guidance on selecting optimal N-terminal pro-B-type natriuretic peptide cut-offs for randomized controlled trials in heart failure. Researchers utilized data from the Swedish Heart Failure Registry, applying N-terminal pro-B-type natriuretic peptide cut-offs ranging from 200 to 5000 picograms per milliliter, which were derived from prior randomized controlled trials. The study calculated one-year incidence proportions to optimize the balance between event enrichment and screening failure across various heart failure subgroups. This optimizes patient selection for clinical trials, improving efficiency and relevance. Article number four. Role of Provocation and Exercise Imaging for the Identification of Candidates for Cardiac Myosin Inhibitors. This study compared the characteristics and therapeutic response of patients with obstructive hypertrophic cardiomyopathy who only showed treatment-qualifying left ventricular outflow tract obstruction during exercise echocardiography, versus those who met eligibility at rest. Researchers assessed the therapeutic response to cardiac myosin inhibitors, specifically mavacamten, in these patient groups. The findings clarify the clinical profile and treatment response of patients who require exercise imaging to establish eligibility for these inhibitors. This work helps identify appropriate candidates for mavacamten therapy. Article number five. Sex- and Phenotype-Specific Prognostic Implications of Body Mass Index in Acute Heart Failure. This study found that the prognostic implications of body mass index in patients with acute heart failure differed according to heart failure phenotype and sex. Researchers analyzed 5271 patients hospitalized for acute heart failure from the Korean Heart Failure three Registry. Body mass index was categorized into low, normal, and high groups using Asia-Pacific criteria. The primary outcome was a composite of two-year all-cause mortality or heart transplantation, showing varying risks across subgroups. Thank you for listening. Don’t forget to subscribe. Keywords heart failure, prognosis, coronary artery disease, machine learning, randomized controlled trials, one-year mortality, body mass index, Swedish Heart Failure Registry, inclusion criteria, acute heart failure, heart failure phenotype, prevention, sex differences, national registry, N-terminal pro-B-type natriuretic peptide, cardiac myosin inhibitors, acute myocardial infarction, mavacamten, phenotype clusters, exercise echocardiography, obstructive hypertrophic cardiomyopathy, clinical strategies, recurrent cardiovascular events, left ventricular outflow tract obstruction, health policy. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post CAD Phenotypes Found for Tailored Prevention 03/28/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded March 28, 2026. This episode summarizes 5 key cardiology studies on topics like oral anticoagulation and caregiver self-care. Key takeaway: Oral Semaglutide Cuts CV Events 14% in Type 2 Diabetes. Article Links: Article 1: Supporting Family Caregiver Health in Heart Failure: Longitudinal Associations Between Heart Failure Caregiver Self-Care and Patient Hospitalizations. (Journal of cardiac failure) Article 2: Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial. (JAMA cardiology) Article 3: Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial. (JAMA cardiology) Article 4: Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study. (Heart (British Cardiac Society)) Article 5: Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study. (Heart (British Cardiac Society)) Full episode page: https://podcast.explainheart.com/podcast/oral-semaglutide-cuts-cv-events-14-in-type-2-diabetes-03-28-26/ Featured Articles Article 1: Supporting Family Caregiver Health in Heart Failure: Longitudinal Associations Between Heart Failure Caregiver Self-Care and Patient Hospitalizations. Journal: Journal of cardiac failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41895678 Summary: Prior research demonstrated that health coaching reduces heart failure caregiver stress and improves caregiver self-care behaviors. This randomized controlled trial assessed the longitudinal associations between improved caregiver self-care and heart failure patient hospitalization outcomes. The study identified how changes in caregiver well-being influenced patient clinical trajectories, underscoring the critical role of caregiver support in patient health. Article 2: Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879791 Summary: The S. O. U. L. randomized clinical trial found that once-daily oral semaglutide reduced the risk of major adverse cardiovascular events by 14 percent compared to placebo. This significant benefit occurred in individuals with type two diabetes and atherosclerotic cardiovascular disease or chronic kidney disease receiving standard of care. This secondary analysis demonstrated the specific changes oral semaglutide induced in long-term cardiovascular risk factors within this high-risk patient group. Article 3: Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879767 Summary: Left atrial appendage occlusion is a critical intervention for patients with contraindications to oral anticoagulation and an increased risk of major bleeding. The Amulet I. D. E. randomized clinical trial meticulously identified the incidence, key predictors, and effective management strategies for major bleeding following left atrial appendage occlusion. This study, involving 1878 randomized patients comparing the Amulet with the Watchman devices, also determined the clinical impact of these bleeding events on patient outcomes. Article 4: Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41887758 Summary: Many patients with coronary heart disease exhibit blood pressure above guideline targets, even with ongoing treatment. European guidelines offer conflicting recommendations regarding patients with on-treatment blood pressure below target, with the 2023 European Society of Hypertension guidelines issuing a class three recommendation to proactively avoid blood pressure below target. The I. N. T. E. R. A. S. P. I. R. E. study established the prevalence and characteristics of patients with coronary heart disease whose blood pressure fell below target levels. Article 5: Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40701798 Summary: Cardiovascular interventions and complications commonly occur after arterial switch operation in patients with dextro-transposition of the great arteries. While complex anatomy, such as ventricular septal defects, is often associated with these outcomes, the independent role of aortic coarctation remained unclear. This multicenter international cohort study analyzed 502 adults from the E. P. O. C. H. A. S. O. registry, precisely defining the long-term morbidity associated with aortic coarctation following arterial switch operation, independent of other complex anatomical factors. Transcript Today’s date is March 28, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Supporting Family Caregiver Health in Heart Failure: Longitudinal Associations Between Heart Failure Caregiver Self-Care and Patient Hospitalizations. Prior research demonstrated that health coaching reduces heart failure caregiver stress and improves caregiver self-care behaviors. This randomized controlled trial assessed the longitudinal associations between improved caregiver self-care and heart failure patient hospitalization outcomes. The study identified how changes in caregiver well-being influenced patient clinical trajectories, underscoring the critical role of caregiver support in patient health. Article number two. Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial. The S. O. U. L. randomized clinical trial found that once-daily oral semaglutide reduced the risk of major adverse cardiovascular events by 14 percent compared to placebo. This significant benefit occurred in individuals with type two diabetes and atherosclerotic cardiovascular disease or chronic kidney disease receiving standard of care. This secondary analysis demonstrated the specific changes oral semaglutide induced in long-term cardiovascular risk factors within this high-risk patient group. Article number three. Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial. Left atrial appendage occlusion is a critical intervention for patients with contraindications to oral anticoagulation and an increased risk of major bleeding. The Amulet I. D. E. randomized clinical trial meticulously identified the incidence, key predictors, and effective management strategies for major bleeding following left atrial appendage occlusion. This study, involving 1878 randomized patients comparing the Amulet with the Watchman devices, also determined the clinical impact of these bleeding events on patient outcomes. Article number four. Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study. Many patients with coronary heart disease exhibit blood pressure above guideline targets, even with ongoing treatment. European guidelines offer conflicting recommendations regarding patients with on-treatment blood pressure below target, with the 2023 European Society of Hypertension guidelines issuing a class three recommendation to proactively avoid blood pressure below target. The I. N. T. E. R. A. S. P. I. R. E. study established the prevalence and characteristics of patients with coronary heart disease whose blood pressure fell below target levels. Article number five. Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study. Cardiovascular interventions and complications commonly occur after arterial switch operation in patients with dextro-transposition of the great arteries. While complex anatomy, such as ventricular septal defects, is often associated with these outcomes, the independent role of aortic coarctation remained unclear. This multicenter international cohort study analyzed 502 adults from the E. P. O. C. H. A. S. O. registry, precisely defining the long-term morbidity associated with aortic coarctation following arterial switch operation, independent of other complex anatomical factors. Thank you for listening. Don’t forget to subscribe. Keywords oral anticoagulation, caregiver self-care, long-term morbidity, atherosclerotic cardiovascular disease, left atrial appendage occlusion, hypertension, dextro-transposition of the great arteries, guideline recommendations, aortic coarctation, type two diabetes, patient hospitalization, blood pressure targets, coronary heart disease, INTERASPIRE study, arterial switch operation, major bleeding, chronic kidney disease, longitudinal associations, major adverse cardiovascular events, heart failure, congenital heart disease, oral semaglutide, cardiovascular risk factors, Watchman device, health coaching, Amulet device. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Oral Semaglutide Cuts CV Events 14% in Type 2 Diabetes 03/28/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded March 28, 2026. This episode summarizes 5 key cardiology studies on topics like microvascular resistance and immunosuppressive therapy. Key takeaway: Ghost Approval: Transplant Drug Access. Article Links: Article 1: Tricuspid regurgitation: standardized stepwise work-up from referral to expert heart valve centre. (European heart journal) Article 2: Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction. (European heart journal) Article 3: Coronary autoregulation: the complex interplay between epicardial and microvascular resistance. (European heart journal) Article 4: Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF Trial. (JACC. Heart failure) Article 5: When Coverage Is Not Access: A Heart Transplant Recipient’s Perspective on Everolimus, FDA Labeling, and the Problem of “Ghost Approval”. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Full episode page: https://podcast.explainheart.com/podcast/ghost-approval-transplant-drug-access-03-28-26/ Featured Articles Article 1: Tricuspid regurgitation: standardized stepwise work-up from referral to expert heart valve centre. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41895721 Summary: A standardized stepwise work-up for Tricuspid Regurgitation was described, guiding patients from referral to an expert heart valve center. Optimal therapy selection for Tricuspid Regurgitation requires an integrated and systematic approach. This approach considers the condition’s etiology, disease stage, comorbidities, operative risk, and anatomical feasibility. Recent advances in surgical and transcatheter interventions have renewed focus on Tricuspid Regurgitation, a common condition historically associated with poor outcomes. Article 2: Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41895321 Summary: This study evaluated the association between Atrial Fibrillation density and ischaemic stroke, investigating whether this temporal episode distribution improves risk stratification compared to Atrial Fibrillation burden. The research utilized data from two U.S. cohorts of patients with cardiac implantable electronic devices that were remotely monitored by the Veterans Health Administration. Atrial Fibrillation density was considered as a potentially more clinically relevant and prognostically important biomarker than traditional classifications based on episode duration or cumulative burden. Article 3: Coronary autoregulation: the complex interplay between epicardial and microvascular resistance. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41895317 Summary: Coronary autoregulation maintains stable blood flow in the coronary circulation despite fluctuations in myocardial perfusion pressure, provided metabolic demands remain constant. The dynamic modulation of microvascular resistance within the coronary microcirculation determines coronary blood flow and is central to this regulatory process. This intrinsic mechanism enables the coronary vasculature to adapt to variations in aortic pressure and epicardial resistance. Article 4: Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF Trial. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41893376 Summary: A post hoc analysis from the P. U. S. H. hyphen A. H. F. trial evaluated the efficacy of natriuresis-guided diuretic therapy in patients with acute decompensated heart failure at risk of diuretic resistance. Diuretic resistance is common in acute decompensated heart failure and is associated with residual congestion and poor prognosis. The study identified diuretic resistance risk using the B. A. N. hyphen A. D. H. F. score, which incorporates blood urea nitrogen, creatinine, natriuretic peptide levels, atrial fibrillation, diastolic blood pressure, hypertension, and home diuretics. Article 5: When Coverage Is Not Access: A Heart Transplant Recipient’s Perspective on Everolimus, FDA Labeling, and the Problem of “Ghost Approval”. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41895624 Summary: This perspective piece introduced the concept of “ghost approval,” where a technically approved medication remains financially or logistically inaccessible to the patient. It highlights that access to immunosuppressive therapy is essential for long-term survival in heart transplant recipients. A first-person experience with everolimus, an M. T. O. R. inhibitor, exemplified this issue, noting its lack of a U.S. Food and Drug Administration indication for heart transplantation contributed to access challenges. Transcript Today’s date is March 28, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Tricuspid regurgitation: standardized stepwise work-up from referral to expert heart valve centre. A standardized stepwise work-up for Tricuspid Regurgitation was described, guiding patients from referral to an expert heart valve center. Optimal therapy selection for Tricuspid Regurgitation requires an integrated and systematic approach. This approach considers the condition’s etiology, disease stage, comorbidities, operative risk, and anatomical feasibility. Recent advances in surgical and transcatheter interventions have renewed focus on Tricuspid Regurgitation, a common condition historically associated with poor outcomes. Article number two. Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction. This study evaluated the association between Atrial Fibrillation density and ischaemic stroke, investigating whether this temporal episode distribution improves risk stratification compared to Atrial Fibrillation burden. The research utilized data from two U.S. cohorts of patients with cardiac implantable electronic devices that were remotely monitored by the Veterans Health Administration. Atrial Fibrillation density was considered as a potentially more clinically relevant and prognostically important biomarker than traditional classifications based on episode duration or cumulative burden. Article number three. Coronary autoregulation: the complex interplay between epicardial and microvascular resistance. Coronary autoregulation maintains stable blood flow in the coronary circulation despite fluctuations in myocardial perfusion pressure, provided metabolic demands remain constant. The dynamic modulation of microvascular resistance within the coronary microcirculation determines coronary blood flow and is central to this regulatory process. This intrinsic mechanism enables the coronary vasculature to adapt to variations in aortic pressure and epicardial resistance. Article number four. Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF Trial. A post hoc analysis from the P. U. S. H. hyphen A. H. F. trial evaluated the efficacy of natriuresis-guided diuretic therapy in patients with acute decompensated heart failure at risk of diuretic resistance. Diuretic resistance is common in acute decompensated heart failure and is associated with residual congestion and poor prognosis. The study identified diuretic resistance risk using the B. A. N. hyphen A. D. H. F. score, which incorporates blood urea nitrogen, creatinine, natriuretic peptide levels, atrial fibrillation, diastolic blood pressure, hypertension, and home diuretics. Article number five. When Coverage Is Not Access: A Heart Transplant Recipient’s Perspective on Everolimus, FDA Labeling, and the Problem of “Ghost Approval”. This perspective piece introduced the concept of “ghost approval,” where a technically approved medication remains financially or logistically inaccessible to the patient. It highlights that access to immunosuppressive therapy is essential for long-term survival in heart transplant recipients. A first-person experience with everolimus, an M. T. O. R. inhibitor, exemplified this issue, noting its lack of a U.S. Food and Drug Administration indication for heart transplantation contributed to access challenges. Thank you for listening. Don’t forget to subscribe. Keywords microvascular resistance, immunosuppressive therapy, heart valve disease, ischaemic stroke, Heart transplantation, P. U. S. H. hyphen A. H. F. trial, acute decompensated heart failure, ghost approval, risk stratification, Coronary autoregulation, Diuretic resistance, Atrial fibrillation, myocardial perfusion, natriuresis-guided therapy, prognosis, surgical intervention, cardiac implantable electronic device, coronary circulation, patient work-up, blood flow regulation, transcatheter intervention, everolimus, biomarker, Tricuspid regurgitation, U.S. Food and Drug Administration. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Ghost Approval: Transplant Drug Access 03/28/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded March 27, 2026. This episode summarizes 5 key cardiology studies on topics like pericarditis and cardiometabolic dysfunction. Key takeaway: Socioeconomic Status Drives Heart Failure Risk. Article Links: Article 1: Senescent obesity signature in breast cancer: a paradigm of reverse cardio-oncology. (European heart journal) Article 2: Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysis. (European heart journal) Article 3: Cardiac involvement in parasitic infections. (European heart journal) Article 4: Inflammatory pathways in atrial fibrillation: mechanisms and novel therapeutic targets. (European heart journal) Article 5: Socioeconomic Correlates of Incident Heart Failure and Consequent Mortality: The All of Us Program. (JACC. Heart failure) Full episode page: https://podcast.explainheart.com/podcast/socioeconomic-status-drives-heart-failure-risk-03-27-26/ Featured Articles Article 1: Senescent obesity signature in breast cancer: a paradigm of reverse cardio-oncology. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41885139 Summary: The field of reverse cardio-oncology found that subclinical and overt cardiometabolic dysfunction, specifically obesity, fuels breast cancer risk and alters tumor biology. This occurs through shared mechanisms including chronic inflammation, hormonal dysregulation, and cellular senescence. Refined obesity phenotypes, such as metabolically healthy versus unhealthy obesity and sarcopenic obesity, demonstrate more accurate stratification of breast cancer risk compared to body mass index alone. This paradigm highlights specific biological links between cardiovascular and oncological diseases. Article 2: Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysis. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41884984 Summary: This prespecified analysis, drawing from two trials on chronic kidney disease and type two diabetes (FIDELIO-DKD and FIGARO-DKD) and one trial on heart failure (FINEARTS-HF), specifically investigated sex differences in cardiovascular-kidney-metabolic syndrome. The analysis consolidated individual participant data to clarify how cardiometabolic risk factors, and their impact, manifest differently between women and men. It provided a comprehensive platform to understand these distinctions in populations with chronic kidney disease, type two diabetes, and heart failure with mildly reduced or preserved ejection fraction. The study’s rigorous data pooling addressed a critical knowledge gap regarding sex-specific outcomes in cardiovascular-kidney-metabolic syndrome. Article 3: Cardiac involvement in parasitic infections. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879141 Summary: Parasitic infections are identified as an important, yet underrecognized, cause of cardiovascular disease, especially in endemic regions and increasingly due to global migration and travel. Cardiac involvement results from either direct parasitic invasion or, more commonly, from immune-mediated and inflammatory mechanisms. These processes primarily affect the myocardium and pericardium, leading to clinical manifestations such as acute myocarditis, dilated or restrictive cardiomyopathy, and pericarditis. This highlights the diverse pathological pathways by which parasites impact cardiac health. Article 4: Inflammatory pathways in atrial fibrillation: mechanisms and novel therapeutic targets. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879137 Summary: Inflammation is definitively identified as a predisposing factor for atrial fibrillation, the most common sustained cardiac arrhythmia. Systemic inflammatory disorders, including autoimmune disorder, diabetes mellitus, and obesity, as well as local inflammation of the heart or pericardium, are directly linked to atrial fibrillation. Inflammation triggers various signaling pathways and directly influences proinflammatory cytokines, which subsequently promote structural and electrical changes in the atria. These mechanisms underscore the critical role of inflammatory processes in atrial fibrillation pathogenesis. Article 5: Socioeconomic Correlates of Incident Heart Failure and Consequent Mortality: The All of Us Program. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41885671 Summary: This study identified prospective associations between socioeconomic status and incident heart failure in adults without pre-existing heart failure. It also demonstrated associations between socioeconomic status and all-cause mortality in patients already diagnosed with heart failure. The analysis utilized data from the National Institutes of Health-run All of Us Research Program. This research provides crucial evidence that both individual and neighborhood measures of socioeconomic status independently correlate with heart failure development and subsequent mortality. Transcript Today’s date is March 27, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Senescent obesity signature in breast cancer: a paradigm of reverse cardio-oncology. The field of reverse cardio-oncology found that subclinical and overt cardiometabolic dysfunction, specifically obesity, fuels breast cancer risk and alters tumor biology. This occurs through shared mechanisms including chronic inflammation, hormonal dysregulation, and cellular senescence. Refined obesity phenotypes, such as metabolically healthy versus unhealthy obesity and sarcopenic obesity, demonstrate more accurate stratification of breast cancer risk compared to body mass index alone. This paradigm highlights specific biological links between cardiovascular and oncological diseases. Article number two. Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysis. This prespecified analysis, drawing from two trials on chronic kidney disease and type two diabetes (FIDELIO-DKD and FIGARO-DKD) and one trial on heart failure (FINEARTS-HF), specifically investigated sex differences in cardiovascular-kidney-metabolic syndrome. The analysis consolidated individual participant data to clarify how cardiometabolic risk factors, and their impact, manifest differently between women and men. It provided a comprehensive platform to understand these distinctions in populations with chronic kidney disease, type two diabetes, and heart failure with mildly reduced or preserved ejection fraction. The study’s rigorous data pooling addressed a critical knowledge gap regarding sex-specific outcomes in cardiovascular-kidney-metabolic syndrome. Article number three. Cardiac involvement in parasitic infections. Parasitic infections are identified as an important, yet underrecognized, cause of cardiovascular disease, especially in endemic regions and increasingly due to global migration and travel. Cardiac involvement results from either direct parasitic invasion or, more commonly, from immune-mediated and inflammatory mechanisms. These processes primarily affect the myocardium and pericardium, leading to clinical manifestations such as acute myocarditis, dilated or restrictive cardiomyopathy, and pericarditis. This highlights the diverse pathological pathways by which parasites impact cardiac health. Article number four. Inflammatory pathways in atrial fibrillation: mechanisms and novel therapeutic targets. Inflammation is definitively identified as a predisposing factor for atrial fibrillation, the most common sustained cardiac arrhythmia. Systemic inflammatory disorders, including autoimmune disorder, diabetes mellitus, and obesity, as well as local inflammation of the heart or pericardium, are directly linked to atrial fibrillation. Inflammation triggers various signaling pathways and directly influences proinflammatory cytokines, which subsequently promote structural and electrical changes in the atria. These mechanisms underscore the critical role of inflammatory processes in atrial fibrillation pathogenesis. Article number five. Socioeconomic Correlates of Incident Heart Failure and Consequent Mortality: The All of Us Program. This study identified prospective associations between socioeconomic status and incident heart failure in adults without pre-existing heart failure. It also demonstrated associations between socioeconomic status and all-cause mortality in patients already diagnosed with heart failure. The analysis utilized data from the National Institutes of Health-run All of Us Research Program. This research provides crucial evidence that both individual and neighborhood measures of socioeconomic status independently correlate with heart failure development and subsequent mortality. Thank you for listening. Don’t forget to subscribe. Keywords pericarditis, cardiometabolic dysfunction, heart failure, inflammation, breast cancer, reverse cardio-oncology, parasitic infections, chronic kidney disease, type two diabetes, cardiac arrhythmia, obesity, mortality, cardiomyopathy, socioeconomic status, cardiovascular disease, cardiovascular-kidney-metabolic syndrome, sex differences, cellular senescence, atrial fibrillation, All of Us Research Program, cardiovascular epidemiology, proinflammatory cytokines, pathogenesis, myocarditis. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Socioeconomic Status Drives Heart Failure Risk 03/27/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded March 26, 2026. This episode summarizes 5 key cardiology studies on topics like conservative care and symptom management. Key takeaway: Early Surgery Reduces Aortic Stenosis Mortality. Article Links: Article 1: Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years. (The New England journal of medicine) Article 2: Renin-Aldosterone Profiles and Cardiorenal Outcomes in Hypertension: A Nationwide Cohort Study. (Journal of the American College of Cardiology) Article 3: Palliative care in cardiovascular medicine. (European heart journal) Article 4: Cardiovascular disease in China: epidemiological evolution and implications. (European heart journal) Article 5: Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease prevention. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/early-surgery-reduces-aortic-stenosis-mortality-03-26-26/ Featured Articles Article 1: Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41880613 Summary: Among asymptomatic patients with severe aortic stenosis, early surgery significantly lowered the risk of operative mortality or death from cardiovascular causes compared to conservative care. This means patients who received early surgery had a reduced composite rate of death during surgery or within 30 days after surgery. The data demonstrated this significant reduction in operative and cardiovascular mortality with early surgical intervention. These findings provided a clear benefit for early surgery in this specific patient population. Article 2: Renin-Aldosterone Profiles and Cardiorenal Outcomes in Hypertension: A Nationwide Cohort Study. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879574 Summary: Renin-independent aldosterone production contributes to adverse cardiorenal outcomes. The study established a definitive association between specific renin-aldosterone profiles and the occurrence of cardiorenal events in adults with hypertension. These findings provide population-based evidence demonstrating the significant role of distinct aldosterone production mechanisms in influencing cardiorenal health in hypertensive patients. The comprehensive analysis identified key patterns linking renin-aldosterone levels to adverse cardiovascular and renal outcomes. Article 3: Palliative care in cardiovascular medicine. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879158 Summary: Palliative care for adults with advanced cardiovascular disease consistently improves patients’ quality of life. It effectively supports caregivers and successfully aligns treatments with patient values and goals. The implementation of palliative care encompasses essential elements such as comprehensive symptom management, proactive advanced care planning, and patient-centered shared decision-making processes. These core components consistently lead to better patient experiences and outcomes in advanced cardiovascular disease. Article 4: Cardiovascular disease in China: epidemiological evolution and implications. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879157 Summary: Cardiovascular disease remains the predominant cause of mortality in China, having undergone significant epidemiological transitions over several decades. This comprehensive review synthesized extensive observational data, revealing key features of cardiovascular disease’s evolving epidemiology across various dimensions within the country. The findings definitively establish crucial trends and interrelationships in cardiovascular disease incidence and prevalence among the Chinese population. This analysis demonstrates how the disease burden has shifted and provides a foundational understanding of its current state in China. Article 5: Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease prevention. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41879156 Summary: Wearable devices are transforming cardiovascular medicine, as they enable continuous remote monitoring of physiological and behavioral measures outside traditional clinical settings. Smartwatches and activity trackers effectively utilize motion and biometric sensors to accurately measure physical activity, sleep quality, heart rate, and rhythm. These devices successfully empower patients to assume a more active role in their health by converting health goals into objective, quantifiable measures. This technological advancement directly contributes to revolutionizing remote monitoring and disease prevention in cardiovascular health. Transcript Today’s date is March 26, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years. Among asymptomatic patients with severe aortic stenosis, early surgery significantly lowered the risk of operative mortality or death from cardiovascular causes compared to conservative care. This means patients who received early surgery had a reduced composite rate of death during surgery or within 30 days after surgery. The data demonstrated this significant reduction in operative and cardiovascular mortality with early surgical intervention. These findings provided a clear benefit for early surgery in this specific patient population. Article number two. Renin-Aldosterone Profiles and Cardiorenal Outcomes in Hypertension: A Nationwide Cohort Study. Renin-independent aldosterone production contributes to adverse cardiorenal outcomes. The study established a definitive association between specific renin-aldosterone profiles and the occurrence of cardiorenal events in adults with hypertension. These findings provide population-based evidence demonstrating the significant role of distinct aldosterone production mechanisms in influencing cardiorenal health in hypertensive patients. The comprehensive analysis identified key patterns linking renin-aldosterone levels to adverse cardiovascular and renal outcomes. Article number three. Palliative care in cardiovascular medicine. Palliative care for adults with advanced cardiovascular disease consistently improves patients’ quality of life. It effectively supports caregivers and successfully aligns treatments with patient values and goals. The implementation of palliative care encompasses essential elements such as comprehensive symptom management, proactive advanced care planning, and patient-centered shared decision-making processes. These core components consistently lead to better patient experiences and outcomes in advanced cardiovascular disease. Article number four. Cardiovascular disease in China: epidemiological evolution and implications. Cardiovascular disease remains the predominant cause of mortality in China, having undergone significant epidemiological transitions over several decades. This comprehensive review synthesized extensive observational data, revealing key features of cardiovascular disease’s evolving epidemiology across various dimensions within the country. The findings definitively establish crucial trends and interrelationships in cardiovascular disease incidence and prevalence among the Chinese population. This analysis demonstrates how the disease burden has shifted and provides a foundational understanding of its current state in China. Article number five. Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease prevention. Wearable devices are transforming cardiovascular medicine, as they enable continuous remote monitoring of physiological and behavioral measures outside traditional clinical settings. Smartwatches and activity trackers effectively utilize motion and biometric sensors to accurately measure physical activity, sleep quality, heart rate, and rhythm. These devices successfully empower patients to assume a more active role in their health by converting health goals into objective, quantifiable measures. This technological advancement directly contributes to revolutionizing remote monitoring and disease prevention in cardiovascular health. Thank you for listening. Don’t forget to subscribe. Keywords conservative care, symptom management, cardiovascular health, remote monitoring, epidemiology, Palliative care, cardiorenal outcomes, Wearable devices, epidemiological transitions, smartwatches, mortality, aldosterone production, Aortic stenosis, operative mortality, China, cardiovascular disease, early surgery, advanced care planning, nationwide cohort study, renin-aldosterone, quality of life, Cardiovascular disease, disease prevention, cardiovascular death, Hypertension. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Early Surgery Reduces Aortic Stenosis Mortality 03/26/26 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded March 25, 2026. This episode summarizes 5 key cardiology studies on topics like healthcare costs and heart failure. Key takeaway: LVAD Reverses Heart Failure, Avoids Transplant. Article Links: Article 1: Recovery From Heart Failure: Microvascular Mechanisms. (Circulation) Article 2: The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants. (Circulation) Article 3: Association Between Copayments and Attendance in Cardiac Rehabilitation: A Nationwide Analysis From the AACVPR Registry. (Journal of the American Heart Association) Article 4: Sociodemographic and Clinical Predictors of Mortality in Adults With Congenital Heart Disease. (Journal of the American Heart Association) Article 5: Joint Associations of Sleep Patterns and Genetic Susceptibility With Dynamic Transitions of Chronic Obstructive Pulmonary Disease and Coronary Heart Disease and the Mediating Role of Inflammatory Biomarkers and Metabolites. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/lvad-reverses-heart-failure-avoids-transplant-03-25-26/ Featured Articles Article 1: Recovery From Heart Failure: Microvascular Mechanisms. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41878819 Summary: Left ventricular assist device support improves cardiac histology and function in patients with heart failure. This improvement sometimes allows patients to avoid heart transplantation after Left Ventricular Assist Device removal. The study investigated the microvascular and cellular programs underlying this observed myocardial recovery. Article 2: The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41878814 Summary: Survival after Fontan palliation for single ventricle heart disease has substantially improved. The Fontan Outcomes Network, comprising 38 congenital heart centers, was established to define the long-term trajectory of these patients. The network successfully enrolled 1121 participants within its first two years, providing a substantial cohort for future longitudinal analysis. Article 3: Association Between Copayments and Attendance in Cardiac Rehabilitation: A Nationwide Analysis From the AACVPR Registry. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41878870 Summary: A. C. V. P. R. Registry. Improving cardiac rehabilitation participation remains a national priority. This study utilized the American Association of Cardiovascular and Pulmonary Rehabilitation registry, analyzing data from 2012 to 2021. The investigation explored the relationship between patient copayments and attendance in cardiac rehabilitation programs, and also patient dropout rates. This analysis addressed the crucial clinical question of how financial barriers impact patient adherence and program completion. Article 4: Sociodemographic and Clinical Predictors of Mortality in Adults With Congenital Heart Disease. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41878868 Summary: Mortality in adults with congenital heart disease is strongly driven by disease complexity. This study investigated the influence of both clinical factors and social determinants of health on all-cause mortality in patients with adult congenital heart disease. Researchers utilized a single-center retrospective cohort from the Mayo Adult Congenital Heart Disease Registry, spanning from 2004 to 2017. The findings contributed to understanding critical factors impacting long-term survival in this complex patient population. Article 5: Joint Associations of Sleep Patterns and Genetic Susceptibility With Dynamic Transitions of Chronic Obstructive Pulmonary Disease and Coronary Heart Disease and the Mediating Role of Inflammatory Biomarkers and Metabolites. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41878867 Summary: Sleep behaviors influence the development of both chronic obstructive pulmonary disease and coronary heart disease. This study explored the associations of specific sleep patterns with dynamic transitions of these conditions. The investigation also addressed the interaction of sleep patterns with genetic susceptibility and the mediating role of inflammatory biomarkers and metabolites. The analysis utilized extensive data from the U. K. Biobank to characterize these complex interrelationships affecting comorbidity. Transcript Today’s date is March 25, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Recovery From Heart Failure: Microvascular Mechanisms. Left ventricular assist device support improves cardiac histology and function in patients with heart failure. This improvement sometimes allows patients to avoid heart transplantation after Left Ventricular Assist Device removal. The study investigated the microvascular and cellular programs underlying this observed myocardial recovery. Article number two. The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants. Survival after Fontan palliation for single ventricle heart disease has substantially improved. The Fontan Outcomes Network, comprising 38 congenital heart centers, was established to define the long-term trajectory of these patients. The network successfully enrolled 1121 participants within its first two years, providing a substantial cohort for future longitudinal analysis. Article number three. Association Between Copayments and Attendance in Cardiac Rehabilitation: A Nationwide Analysis From the A. A. C. V. P. R. Registry. Improving cardiac rehabilitation participation remains a national priority. This study utilized the American Association of Cardiovascular and Pulmonary Rehabilitation registry, analyzing data from 2012 to 2021. The investigation explored the relationship between patient copayments and attendance in cardiac rehabilitation programs, and also patient dropout rates. This analysis addressed the crucial clinical question of how financial barriers impact patient adherence and program completion. Article number four. Sociodemographic and Clinical Predictors of Mortality in Adults With Congenital Heart Disease. Mortality in adults with congenital heart disease is strongly driven by disease complexity. This study investigated the influence of both clinical factors and social determinants of health on all-cause mortality in patients with adult congenital heart disease. Researchers utilized a single-center retrospective cohort from the Mayo Adult Congenital Heart Disease Registry, spanning from 2004 to 2017. The findings contributed to understanding critical factors impacting long-term survival in this complex patient population. Article number five. Joint Associations of Sleep Patterns and Genetic Susceptibility With Dynamic Transitions of Chronic Obstructive Pulmonary Disease and Coronary Heart Disease and the Mediating Role of Inflammatory Biomarkers and Metabolites. Sleep behaviors influence the development of both chronic obstructive pulmonary disease and coronary heart disease. This study explored the associations of specific sleep patterns with dynamic transitions of these conditions. The investigation also addressed the interaction of sleep patterns with genetic susceptibility and the mediating role of inflammatory biomarkers and metabolites. The analysis utilized extensive data from the U. K. Biobank to characterize these complex interrelationships affecting comorbidity. Thank you for listening. Don’t forget to subscribe. Keywords healthcare costs, heart failure, sleep patterns, cardiac function, long-term outcomes, copayments, patient registry, mortality predictors, chronic obstructive pulmonary disease, metabolites, patient attendance, congenital heart disease, inflammatory biomarkers, cardiac rehabilitation, Fontan palliation, Left ventricular assist device, social determinants of health, genetic susceptibility, adherence, adult congenital heart disease, coronary heart disease, myocardial recovery, heart transplantation, clinical factors, single ventricle heart disease. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post LVAD Reverses Heart Failure, Avoids Transplant 03/25/26 first appeared on Cardiology Today.